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This evaluation of the Community Detox is highly 
anticipated by Novas for many reasons. When we first 
began to consider options for our service users and 
their accessibility of drug treatment services, we were 
introduced to the model of community detox treatment. 
We identified that it was an option that was readily 
accessible and provided an immediate response to those 
who were looking to engage in treatment around their 
benzodiazepine and methadone use. We accessed the 
model through the Ana Liffey service who had designed 
the protocols with Progression Routes. 
Novas envisaged the Community Detox as one of many 
potential solutions to support homeless service users to 
detoxify from benzodiazepines and methadone, however 
over time the wider community in the Mid-West has been 
the main benefactor of the service. The Community Detox 
in its current format is reaching many homes throughout 
the region where for one reason or another the person 
in addiction cannot access residential drug treatment 
services. For some they continue to care for their families 
and children and leaving for residential treatment is not an 
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option. For others, confidence is an issue and group work 
(which is a feature of many programmes) is problematic. 
Whatever their own personal reason for accessing the 
Community Detox, over 130 people in the region have 
chosen to access drug treatment via this model in the 
period May 2012 to June 2015. 
This service sits within a range of other drug treatment 
services that attempt to offer as wide a choice as possible 
for those who want to access drug treatment. Research 
shows us that when you have a wide, disperse population 
with a combination of needs, the response to meet those 
needs also needs to be diverse. The Community Detox 
holds a unique position in the Mid West’s suite of drug 
treatment responses and has provided a regional and 
national picture that was heretofore not present. Those 
who access this service are clear evidence of the continued 
need for bespoke services that respond to the ever-
changing dynamic that a drug user might find themselves 
in. Our mothers, fathers, grandparents, siblings, children 
need our support when drug treatment is requested – the 
Novas Community Detox is one such response that is 
meeting a growing need in the region. 
The Community Detox is a funded service and employs 
three part-time staff, which is key to its success to-date. 
In other regions Community Detox has been offered 
in a volunteer-led capacity and numbers anecdotally 
have been much lower than those referred to the 
Novas Community Detox. Services like this, need to be 
adequately resourced for solid and meaningful outcomes. 
Novas works very closely with the Mid West Regional 
Drug and Alcohol Forum who have funded the service 
in partnership with the HSE since its inception in 2012. 
Without this support, we would not have as many 
accessing or remaining in the service. This model is a clear 
demonstration of successful resource allocation meeting 
the identified need in a community. 
Novas are heartened by the successful outcome of this 
evaluation and take it as a green light to expand the 
protocols to cover other areas of addiction that are being 
increasingly referred to the service; alcohol, cannabis 
and heroin to name but three. Novas has been supporting 
people with drug-related issues since we opened our 
first low-threshold homeless service in Limerick in 2002, 
operating within a harm reduction model. Over the past 
14 years, we have developed many housing services as 
well as health and recovery based initiatives. We view the 
Community Detox as a very successful health initiative 
that will continue to provide routes for those who want to 
tackle their benzodiazepine and methadone use and other 
drugs into the future. 
Finally, I wish to thank Ronni Greenwood for carrying 
out this evaluation and treating the data with the care and 
attention it deserved. I also want to thank the staff in the 
service, without whom, it would not be as successful as it 
is today; Julie McKenna, Maurice Crowe and Dan Taylor. 
Thank You.
Anne Cronin
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In 2007, an Expert Group came together in 
Dublin to discuss and respond to community 
members’ reports that they could not access needed 
detoxification services (O’Reilly, Reaper, & Redmond, 
2005). Then, as now, available residential detox 
supply could not meet demand. Limited funding 
for inpatient resources and intake criteria exclude 
many people from needed inpatient services. 
Outpatient detox is not an option for most of 
these individuals, because general practitioners 
are reluctant to provide this service for a number 
of reasons, including increased risk of overdose, 
prescription abuse, and insufficient psychosocial 
supports to facilitate outpatient detox (Progression 
Routes, 2011). As a consequence, many members 
of the community who had both need for and 
motivation to detox had no means through which to 
do so. 
In response to this need, the Expert Group 
formed a multidisciplinary steering committee 
composed of addictions experts. This group came 
together with Progression Routes Initiative (PRI) to 
draft a protocol for community-based detox. The 
protocols outline a set of minimum standards for 
medical and psychosocial support for community-
based detox that are aligned with national strategic 
documents (e.g., Doyle & Ivanovic, 2010; HSE, 
2010). The minimum standards for a community-
based detoxification outlined in the protocols are: 
provision of interagency care planning, relapse 
prevention, and medical supports (Progression 
Routes, 2011). 
Once the initial protocols were finalized, they 
were pilot tested for 18 months beginning in April 
2007 in the North Inner City region of Dublin. 
This single-site community detox program was 
evaluated in early 2009. PRI reported generally 
positive client outcomes and cost effectiveness 
findings (Progression Routes, 2011, p. 5). In 2010 an 
expanded Community Based Detoxification Steering 
Group came together and revised the protocol 
in light of the pilot evaluation findings. In 2011, 
local and regional drugs tasks forces were invited 
to participate in a national community-based 
detoxification pilot programme (Dermody & Lyons, 
2011; Progression Routes, 2011). 
In 2012, when the Midwest Regional Drug Task 
Force released a Call for Expression of Interest for 
experienced drugs services providers to apply for 
funding for treatment and rehabilitation initiatives 
for substance misusers in the Midwest Region, 
Novas Initiatives responded with an application for 
funding to participate in the national community 
detox pilot programme on the basis of findings from IN
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Chapter 01 | Introduction
a phenomenological study of self-detoxification (van 
Hout & Bingham, 2012), of the experience gained 
in the first six months of the Novas CD programme, 
and because of the gap in services caused by a 
lack of available funding for full residential detox 
service. With these funds, Novas Initiatives aimed 
to create and deliver a community detox team 
within the umbrella of their homeless services at 
McGarry House, which is a low threshold hostel 
accommodation in Limerick City. At the time, a 
significant number of McGarry House residents 
misused benzodiazepines but could not avail of 
residential detox services because they did not 
meet eligibility criteria and because waiting lists 
were very long. Further, McGarry House residents’ 
GPs were reluctant or refused to deliver outpatient 
detox because of overdose risk, risk of prescription 
abuse, and lack of adequate supports. 
The management of Novas Initiatives proposed 
to create a funded, 60 hour per week service in 
which a community detox team would work with 
homeless clients toward their detoxification goals. In 
fact, the Novas CD site proved to be the only funded 
community detox programme in the national pilot 
programme; all other pilot sites relied on voluntary 
hours contributed from existing resources. The 
idea was to deliver a service focused on homeless 
services users (whether or not they received 
services from Novas Initiatives). Novas management 
aimed to deliver the Progression Routes protocols 
within an interagency approach. More specifically, 
the Novas Initiatives CD team would link with 
GPs, other drugs services, and with voluntary and 
statutory bodies such as child welfare, probation 
services, and community welfare officers. The team 
would complete intake assessments, evaluations, 
and care planning. They would also provide holistic 
treatments such as cognitive behavioural therapy, 
motivational interviewing, relapse prevention, 
and anxiety management. Through interagency 
collaboration, the team would link clients to 
other resources in the community to aid relapse 
prevention, including job skills training, life skills 
training, resettlement, and recreation. 
The Novas Community Detox Team began 
enrolling service users in 2012. Early on it became 
apparent that the target population, residents of 
McGarry House and clients of other homeless 
services did not meet the eligibility criteria as 
outlined in the Progression Routes protocols, but 
that there was a great need for community-based 
benzodiazepine detox services in the broader 
area covered by the Midwest Regional Drugs Task 
Force. The team broadened the scope of its target 
population and increased its efforts to mobilize 
referrals beyond the homeless population. As 
a consequence, Novas Initiatives’ management 
created additional pathways to serve the homeless 
population’s substance misuse needs by enhancing 
the role of the dual diagnosis worker in McGarry 
House, who also became a member of the Novas CD 
team. 
Novas Initiatives’ management sought an 
independent local programme evaluation to assess 
the fidelity and outcomes of their community 
detox programme. Findings from this evaluation 
are presented and explained in this report. In the 
following chapters, the reader will find a description 
of the methodology used to collect data for this 
evaluation (Chapter 3); a fidelity assessment 
(Chapter 4); client outcomes (Chapter 5); and key 
features and qualities of service delivery (Chapter 
6). Chapter 7, the final chapter, outlines the key 
findings and recommendations for programme 
development. 
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There were five objectives for this 
evaluation: 1) to collect evidence for 
the fidelity of the Novas Community 
Detox to the original Progression 
Routes Protocols; 2) to describe the 
population of clients served by the 
Novas CD programme; 3) to assess 
the delivery of the programme; 4) 
to assess the outcomes and impact 
of the programme; and 5) draw 
conclusions for sustainment and 
development of the programme. 
The evaluation design was mixed 
methods. This means that qualitative 
data and quantitative data were 
combined in data analysis intended 
to achieve the five evaluation 
objectives.
The data collected and analysed to compile this 
report were obtained from the following sources: 
CLIENT CASE NOTES
It was agreed with the CD Coordinator that 
the six months leading up to the beginning of the 
evaluation period would be included in the case 
note review. Thirty client records were included 
in this sample. These case records included 
information about each phase of the detox process 
and included the team’s approach to engagement, 
preparation, detox, disengagement, and aftercare. 
Using the Detox Protocols as a guide, the following 
assessment rubric was developed and used to 
document the contents of each case note file: 
M
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DIMENSION EXPECTED DOCUMENTATION
CASE NOTE CHARACTERISTICS
• Status (closed or open case)
• Number of case note entries  
• Included and completed forms: TOP; ICF; 
Record of disengagement 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
TEAM ACTIVITIES AND SUPPORTS WITH CLIENTS
• Evidence of interagency care planning
• Evidence of working with client to build 
skills and knowledge about drug use, risk, 
and relapse
• Medical supports – documentation of regular 
medical visits
• Evidence of evaluation of suitability
• Evidence of meeting detox entry 
requirements
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
BROKERING STAGE
• Referral to programme
• Contact with physician
• Explanation of the programme to client 
and keyworker where relevant – protocols 
shared, contact information shared
• Risk information and agreement 
• Suggested next steps
• Completed Initial Referral Form
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
PREPARATION STAGE
• Discussion of risk associated with 
withdrawal, seizures and overdose
• Entry criteria
• Evidence of relapse prevention and care 
planning – minimum of one hour per week
• Evidence of addressing barriers to detox  
with client
• Drug diaries 
• Sharing of drug diaries and care plan with 
physician
• Completed TOP form
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
DIMENSION EXPECTED DOCUMENTATION
DETOX STAGE
• Commencement of detox
• Evidence of client adherence (or not) with 
detox plan
• Evidence of weekly meetings with client, 
topic of meetings, and next plans
• Missed appointments
• Evidence of timeframe prescribed by GP
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
AFTERCARE STAGE
• Evidence of weekly meetings
• Evidence of working with client to prevent 
relapse and promote recovery
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
DISENGAGEMENT STAGE
• Note of client disengagement behaviours
• Meetings missed & KW follow up
• Evidence of topping up and response to this
• Efforts to contact client
• Disengagement form
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
TABLE 1. CASE NOTE REVIEW
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Standard protocols for ethical treatment of 
human participants were followed for every 
aspect of data collection. All participants were 
given information about the purpose and nature 
of the interview questions. All participants were 
assured that the evaluator would protect their 
confidentiality to that confidentiality is possible 
given the nature of this evaluation. Because the 
interviewees make up a small sample of a small 
community, it is possible that a reader of this report 
could draw some conclusion about the identity 
As with any evaluation, there are some 
limitations to the data collected, and readers should 
keep these limitations in mind when assessing 
the findings. First, at the time of the evaluation, 
the team was in the midst of transferring over 
case notes from a paper-based to a computer-
based system. As a consequence, only the paper 
case notes, and not the electronic case notes, were 
accessed for review. 
Second, because this is a select sample of 
individuals who opted into the evaluation, the 
findings may not be representative of all clients, all 
GPs, or all Key Stakeholders. Third, the design of 
this evaluation, which does not include any type 
The findings from quantitative and qualitative 
analyses are organized into three chapters. Chapter 
4 presents the results of a fidelity assessment 
in which information about the delivery of the 
programme from clients, Key Stakeholders, GPs, 
and the team are used to gauge the extent to which 
the program evidences fidelity to the original 
Progression Routes Protocols. Chapter 5 includes a 
description of the Novas client population and their 
engagement with the services. Chapter 6 presents 
of some of the interviewees, and this limitation 
was communicated to each interviewee. The 
final draft has been approved by Key Informants 
who, by dint of their role, could potentially be 
identified by the information they provided. No 
identifying information about any client was 
included in the SPSS data file or in any of the case 
notes documentation. All identifying information is 
protected and will be deleted/destroyed when the 
final version of this report is agreed. 
of pre-implementation assessment, means that it is 
not possible to draw conclusions about cause-effect 
relationships between the implementation of the 
service and key outcomes. However, because the 
evaluator was able to draw on multiple sources of 
data from a wide range of individuals involved in 
the project with different capacities, interests, and 
agendas, we can have confidence in the snapshot 
image of Novas CD that emerged from the analysis 
findings. A number of consistencies emerged 
across the quantitative data, the case notes review, 
and interviews with team members, GPs, key 
stakeholders and clients, and are described in this 
report.
findings about the overall experience, effectiveness, 
and efficacy of the programme as described 
by clients, team members, key stakeholders, 
and GPs. The report concludes with Chapter 7, 
which includes a summary of key findings and 
recommendations for development planning. 
QUANTITATIVE DATA
All available quantitative data from client 
records were coded and entered into an SPSS data 
file. Statistical analyses were then run on inputted 
data. Findings are presented in Chapter 5. See the 
Appendix for a full list of available quantitative 
data. 
QUALITATIVE INTERVIEWS
Qualitative interviews were conducted in person 
and digitally recorded when possible. When not 
possible, phone interviews were conducted and 
notes taken during and after the interview. Each 
recorded interview was transcribed verbatim. 
These interview data were used as the basis of 
findings presented in Chapters 4 and 6. 
Individual client Interviews: The evaluator 
requested a list of clients with a range of types of 
engagement with the programme, ranging from 
disengagement during the engagement period 
to disengagement after full completion of the 
programme. A list of 21 names was provided by 
the team to the Evaluator, who then contacted a 
selection of these individuals by text and by phone. 
Eight clients were interviewed, 5 in person and 
3 by phone. Three interviewees were men and 
five were women. Semi-structured interviews 
were constructed in consultation with the CD 
Coordinator. The interview guide is included the 
Appendix.  
Individual GP Interviews: The evaluator 
requested a list of GPs with varying degrees of 
engagement with Novas CD. A list of 16 GPs with 
their contact details was provided by the Novas 
CD team.  The evaluator attempted to arrange in-
person interviews, which where digitally recorded 
and transcribed verbatim. When face-to-face 
interviews were not possible, phone interviews 
were conducted. It proved to be difficult to recruit 
many GPs to interviews, partly because of timing 
and partly because their schedules did not allow 
time for this activity. Interviews were eventually 
completed with five GPs, three by phone and two 
face-to-face. A semi-structured interview guide was 
created in consultation with the CD Coordinator.
Key stakeholder interviews: The CD Coordinator 
provided the Evaluator with a list of 7 Key 
Stakeholders to interview for this evaluation. Five 
of these seven Key Stakeholders were interviewed. 
One Key Stakeholder was on annual leave an 
unavailable for interview. Another Key Stakeholder 
expressed interest in contributing to the evaluation 
but the evaluator was not able to secure the 
interview. 
Team member interviews: All three team 
members were interviewed on at least two 
occasions. These interviews focused primarily on 
the delivery of the programme at each stage of the 
protocol, adherence to the protocols, relationships 
with clients, relationships with one another, 
workload, responsibilities, development ambitions, 
challenges, and constraints to delivering the 
programme. The CD Coordinator was interviewed 
individually, and the two team members were 
interviewed together. 
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“Model fidelity” refers to the extent 
to which a given programme adheres 
to an intervention protocol. In this 
case, we aimed to assess Novas 
Community Detox’s fidelity to the 
Progression Routes Community 
Detoxification Protocols. Fidelity 
assessments identify the ways in 
which a model is adapted, modified, 
expanded, and enlarged. Some 
adaptations strengthen and enhance 
the delivery of a programme, and it is 
important to be able to identify key 
improvements and advancements 
made through model adaptation.  
“Model drift” refers to “the 
unplanned, gradual altering of an 
intervention” (Hagermoser, Sanetti 
& Kratochwill, 2009, p. 452). Model 
drift can lead to “model dilution”, 
which occurs when a protocol 
is “watered down” on some key 
aspects so that the programme is not 
delivered at its full strength, or does 
not reach its intended population.  
2322
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In the Community Detox Protocols, there are 
three key roles: Broker, Key Worker, and Doctor. 
At its inception, these three roles were clearly 
delineated in the Novas CD programme. Soon after 
the programme was initiated, however, the broker 
and key worker roles were expanded and adapted 
in several important ways. In this section I describe 
how these roles are currently performed by the 
team members, the extent to which they adhere 
to the original model, and draw conclusions about 
adaptations for programme outcomes. 
BROKER ROLE
This section reviews the fidelity of the Novas 
Community Detox Broker Role to the description 
of the role in Appendix B of the Progression Points 
Community Detox Protocol. In the original protocol, 
a very limited time commitment of one hour per 
week was allocated to the broker role, although 
it is defined by a wide range of time consuming 
tasks and responsibilities that would seem, in 
practice, to require much more than one hour per 
week. The broker responsibilities as outlined in the 
protocols include: 1) being the first point of contact 
for community detox in the local area and region, 2) 
promoting the Community Detox in the local area 
or region, 3) supporting the doctors and key workers 
to work under the protocols, 4) responding to inter-
agency challenges as these arise, and 4) participating 
in the evaluation of the national pilot. 
First Point of Contact. The person who 
is responsible for the broker role is the CD 
Coordinator, and the CD Coordinator effectively 
shares responsibility with the team members for 
being the first point of contact in the region for 
client referrals. The broker/CD Coordinator serves 
as the first point of contact for other drugs services 
in the region, other voluntary and statutory bodies, 
and for the key stakeholders who support the team 
and work with the team to provide interagency 
support. The broker/CD Coordinator is responsive to 
interagency concerns. 
Programme Promotion. Interviews with 
doctors, team members, key stakeholders, and the 
broker/CD Coordinator indicate that the broker/
CD Coordinator has successfully promoted the 
Community Detox in the region. Doctors in 
the region are familiar with the programme, as 
evidenced by case note review, the number doctors 
in the region who refer to the programme, and by 
interviews with local key stakeholders from other 
drugs services. Case notes showed that 64 doctors 
were named as clients’ primary GPs. Three of these 
doctors were named by six to eight clients, five 
doctors were named by either four or five clients, 14 
GPs were named by two or three clients, and 42 GPs 
were named by only one client. 
In many ways, the broker/CD Coordinator has 
accomplished the work raising the profile of the 
community detox, in that the Novas CD is well-
connected to the other voluntary and statutory 
bodies in the region. This visibility is sustained and 
strengthened through the team’s collective work of 
giving presentations about the service, such as at 
residential facilities and to the local GP continuing 
education group. The broker and team explained 
that every six months or so they replenish 
promotional materials like flyers and pamphlets in 
public locations, such as doctors’ offices and other 
drugs services. The visibility of these materials was 
confirmed in interviews with key stakeholders. 
Further, visibility is ensured through their 
continued outreach to more doctors in the region 
and their weekly presence at the LDAS, in North 
Tipperary, and County Clare. 
Support to Doctors and Keyworkers. Interviews 
with team members and doctors, along with case 
notes reviews demonstrated the many and varied 
ways in which the broker supports doctors and key 
workers to work under the protocols. Interviews 
with doctors revealed that doctors’ impressions 
of the broker/CD Coordinator are that of a highly 
competent, reliable, and professional expert in the 
field of addictions and recovery. The broker/CD 
Coordinator works with the other team members 
throughout all phases of the programme, including 
the engagement phase, in which assessment and 
information are delivered to the client; doctors are 
contacted to request their supervision of client’s 
detox; and supervision, advice, and guidance 
are provided to both doctors and key workers. 
Interviews with doctors indicated that the doctors 
value the broker/CD Coordinator’s expertise in 
delivering the protocols. Finally, because the 
broker/CD Coordinator and team key workers work 
so closely together, supervision is on an ongoing 
basis rather than on the six-weekly basis that is 
recommended in the Community Detox Protocols. 
Respond to inter-agency challenges. In the course 
of this evaluation, little evidence was uncovered of 
inter-agency challenges. According to interviews 
with key stakeholders, the broker and the team 
have successfully managed to establish the 
programme as an important component of the 
continuum of care in the region, and the programme 
works cohesively and with complementarity 
to other key services in the region, such as Ana 
Liffey and the LDAS. The programme appears to 
work harmoniously with other bodies such as 
the Gardaí, probation services, and child welfare, 
which, in turn, facilitates care planning and relapse 
prevention for clients. 
The broker/CD Coordinator organizes regular 
steering group meetings. The Novas Community 
Detox Steering Committee was created in the early 
days of the programme. Quarterly meetings are held 
and the membership consists of referring bodies 
and local stakeholders who can advise on important 
programming issues and challenges that arise in the 
effective delivery of community detox within this 
particular context. 
Participate in the national pilot evaluation. The 
broker/CD Coordinator did participate in the 
evaluation of the national community detox pilot, 
but their site was not included in the final report, 
which has not been made publicly available and 
was not made available to this evaluator to review 
and compare outcomes. The broker/CD Coordinator 
reported that he made available a great deal of data 
to the national evaluators, and a good deal of the 
team’s time was given to providing interviews to 
the national evaluators. Because no report has been 
published, and it is the broker/CD Coordinator’s 
understanding that the Novas programme will not 
be included in that report; therefore, management 
chose to undertake the current evaluation. 
In summary, the broker role was adapted 
and expanded in the Novas Community Detox 
Programme. The one hour per week allotted in the 
protocols is a twenty hour a week position, and 
the broker serves as a manager (CD Coordinator) 
for the Novas Community Detox team and for the 
Respite Service. The manager is responsible for 
the brokering tasks that remain in the adapted 
configuration, but extend to governance and 
oversight, team management, and liaison with 
the parent organization, Novas Initiatives. In 
addition, the CD Coordinator serves as a key 
worker, contributes to weekly drop-in hours, and 
works directly with clients. Interviews with team 
members indicate that the CD Coordinator carries 
out both the duties of a team member and the CD 
Coordinator to deliver the protocols with a high 
degree of fidelity and clinical oversight. He provides 
effective clinical supervision to team members 
and supports the team in their work to effectively 
provide care planning and relapse prevention 
supports to clients in their delivery of all stages of 
the programme. 
KEYWORKER ROLE
This section assesses Novas Community Detox’s 
fidelity to Keyworker Role as outlined in the 
Progression Routes Community Detox Protocol. One 
of Novas’ adaptations to the original protocol is the 
development and expansion of its own community 
detox team to include in-house keyworkers. Early 
Team Roles, Responsibilities, and Competencies
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attempts to arrange service level agreements 
with other social service agencies did not yield 
a significant uptake, and so the CD Coordinator 
has ceased efforts to broker key workers from 
other services. External key worker services were 
often reluctant to take on the key working role in 
community detox for a variety of reasons including 
their already stretched staff, and importantly, their 
unfamiliarity with and lack of training in drug and 
alcohol supports. 
Although the Novas Community Detox 
Programme continues to utilize the services of 
keyworkers employed by other agencies through 
Community Detox Participation Agreements, 
virtually all keyworking is delivered by the 
Community Detox Programme Team. These team 
members, including the CD Coordinator, carry out 
all the tasks listed in the keyworker role description 
in the detox protocols. This is an important 
adaptation that enhances the delivery and reach of 
the community detox programme, and one which, 
according to key stakeholders, has established the 
Novas Community Detox as an important resource 
for drug treatment in the Midwest Region. 
Key workers complete assessments with all new 
clients. Assessments may occur at the weekly drop-
in hours that the team holds at the Limerick Drug 
and Alcohol Service’s offices, in their own suite of 
offices at McGarry house, or any other location of 
the client’s choosing. This includes a risk assessment 
with each client, a discussion of the risks associated 
with detox, and an explanation and overview of the 
Novas CD programme. These assessments include 
completion of all forms included in the Community 
Detox Protocols.
Key workers develop an individually tailored, 
client-led care plan, and review these plans 
regularly in team meetings. The keyworking team 
works together to develop and deliver a holistic 
care plan for the client that addresses her or his 
specific support needs. This often includes working 
with families to re-establish family supports. It also 
often includes linking the client to other services, 
especially housing services, medical services, 
and social welfare services. In many cases, other 
services are not equipped to deal with a client’s co-
occurring issues, and so the team will support the 
client on a particular need until she or he qualifies 
for other needed services, such as bereavement 
counselling. At this point, the team advocates on the 
client’s behalf to link into the needed service. 
Key workers offer clients some in-house services 
beyond weekly meetings, including acupuncture, 
meditation, and yoga. By offering these services, 
the team is able to introduce clients to new, more 
adaptive means to cope with stress and anxiety, 
which they can use in place of benzodiazepines. 
These services are a core component of the team’s 
holistic approach to relapse prevention. The team’s 
plans to expand their service to incorporate more 
resources for clients are described in Chapter 7.  
Interviews with team members, doctors, clients, 
and key stakeholders indicate that the team meets 
and exceeds the minimal standards for the delivery 
of community detox as outlined in the Community 
Detox Protocols. For example, team members 
described the range of interagency supports with 
which they link eligible clients, their advocacy 
on behalf of clients with voluntary bodies like 
housing services, with statutory bodies such as 
child protection and probation services, intensive 
engagement with family members, and their efforts 
to support clients in re-engaging with, or initiating 
new occupational interests whether educational, 
occupational, social, or wellness-related. Fully 
integrated into these activities are efforts toward 
relapse prevention. 
Relationship building is a key ingredient in 
this team’s approach. Team members prioritize 
the development of a strong foundation of mutual 
trust between the team and client, so that clients 
can fully, and without fear of judgment, discuss 
their drug use histories, personal stories of trauma, 
abuse, or other experiences that precipitated their 
drug misuse. In doing so, team members are able to 
work intimately with clients to gain insight into and 
knowledge about their drug misuse and to develop 
clients’ own personal capabilities around relapse 
prevention. Relationship building with doctors is 
also an important aspect of the keyworker role. Key 
workers actively cultivate and maintain strong lines 
of communication with doctors and in most cases 
attend regular doctor appointments with clients. 
Interviews with doctors, team members, and clients 
clearly indicate that channels of communication are 
open amongst all parties involved in a client’s detox. 
Client Eligibility and Intake
One important aspect of model fidelity is 
whether a programme reaches its intended 
client group. Review of case notes and referral 
documentation, and interviews with team members 
indicate that almost all individuals who approach 
or are referred to the detox programme meet the 
criteria for a benzodiazepine detox. For several 
reasons, including ineligibility due to high daily 
dosages and barriers to access caused by long 
waiting lists, these individuals cannot gain access 
to residential in-patient treatment. The Novas 
Community Detox programme fills this gap in 
service availability for a cohort of individuals in 
the region who badly need medical detox from 
benzodiazepines. 
Based on available data, it is difficult to pinpoint 
how many referred individuals do not meet the 
eligibility criteria as outlined in the Community 
Detox protocols. The team has broadened the 
definition of an eligible referral, is willing to take 
on, and has taken on, individuals whose usage falls 
outside that which is described in the protocols. 
Further, the team works with clients with complex 
dual diagnosis and dual addiction needs, although 
they sometimes face challenges linking with a 
doctor who is willing to detox someone with active 
poly-substance use or active psychiatric symptoms. 
As a consequence, the clients with whom the team 
works often have multiple and complex support 
needs and does not refuse services to individuals 
who might be labelled “difficult-to-serve”.  
Phases of Community Detox: Engagement, Preparation,  
Detox, and Aftercare
ENGAGEMENT
In the engagement phase, which in the 
Progression Routes Community Detox Protocols 
is called the Brokering Phase, service users are 
referred to the programme, team members complete 
the initial assessment, and all forms included in the 
Community Detox Protocols. The responsibilities 
of the broker at the engagement phase have 
been absorbed into the CD Coordinator and team 
member roles. Instead of brokering the keyworker 
role, Novas CD staff assumes the keyworker role. 
The team does continue to work with a few other 
services in the manner outlined in the Community 
Detox protocols, but efforts toward cultivating 
these relationships have been discontinued. This 
adaptation is discussed in more detail in the final 
section of this chapter. It is a key adaptation that 
goes beyond the protocols in important ways, and 
which evidence indicates improves delivery, staff 
outcomes, and client outcomes. 
Engagement may be initiated by a service 
user, a doctor, or another voluntary or statutory 
organization. Novas CD operates weekly drop-in 
hours at the LDAS, where service users can meet 
with team members and explore the possibility 
of community detox. These drop-in hours are an 
important and heavily used entry point to the 
community detox programme. The team also 
accepts referrals from anyone – from doctors, from 
other drug services, from statutory bodies, and self-
referrals. 
Regardless of the entry pathway, in the 
engagement phase the client engages with the 
team and the team describes the service to the 
client. During this phase the team explains the 
risks and benefits of detox to the client, explains 
the drug diaries and the subsequent phases of the 
programme, and helps the client begin to complete 
the drug diaries. For clients whose entry point is 
through LDAS drop-in hours, the engagement phase 
ends when the team invites the client to begin 
meeting in regularly scheduled appointment hours 
in McGarry House rather than in LDAS. For clients 
with more complex support needs, this shift signals 
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that the team has a deepened level of confidence 
in the client’s commitment to detox that seems, in 
turn, to reinforce the client’s commitment to the 
detox enterprise. At this point, the client and team 
are ready to commence the preparation phase. The 
team member who is the primary link to the client 
ensures that the doctor, the team, and the client 
have shared information and mutual understanding 
of the client’s detox goals. 
PREPARATION
According to the protocols, the service user and 
key worker begin key working sessions prior to the 
beginning of dose reduction. This is to support the 
service user to meet entry criteria by establishing 
or reviewing the care plan and to begin relapse 
prevention work. 
Clients meet on a minimum of four occasions 
with a Novas Community Detox keyworker and 
during this time the team takes a holistic approach 
to care planning. Interviews with team members 
indicate that these meetings are individually-
tailored and client-led. The team pays keen 
attention to the client’s social and psychological 
needs and strengths, within her or his local context. 
Clients are linked to other local services that can 
meet their support needs such as housing or social 
welfare payments. Keyworkers work with clients’ 
families to repair and strengthen relationships, and 
they work individually with clients to develop 
clients’ self-confidence and the personal resources 
they need to sustain the detox. 
Interviews with the team indicate that they 
place a great deal of importance on establishing 
the client-keyworker relationship during the 
preparation phase. “Meeting them where they are 
at” is a core principle for this team. This client-led, 
consumer choice-driven approach appears to be 
one of the key ingredients of the success of this 
team in encouraging and empowering clients 
toward a successful detox. Through this approach 
the team is able to cultivate the client’s trust and 
confidence that with the team’s support, she or he 
can sustain a detox. Interviews with both staff and 
clients indicate that the team works with clients 
at the clients’ own paces toward meeting the entry 
requirements for detox, regardless of how long 
and slow this work may be. The team continues to 
engage with clients in an open-ended time frame, 
led by client interest and motivation, until the client 
is ready to move to the detox phase. 
Interviews with team members revealed 
the importance of the preparation period to 
relationship building. The preparation period is 
used to learn about clients’ use patterns, their life 
histories, and in that, the causes that underpin 
their current overreliance on benzodiazepines. 
Importantly, interviews with clients revealed how 
they experience these weekly meetings – uniformly 
– as “having a chat”, as a private space in which they 
can talk about what is going on in their lives, their 
problems, and their substance misuse, with full 
acceptance and without fear of judgment or reprisal. 
Clients frequently explained how important it was 
that they felt that they could tell the team members 
anything and everything about their lives. Clients 
felt, through the team member’s actions, that the 
team was committed to them and their recovery. 
This feeling, of another person’s commitment to 
one’s own well-being, seems a vital aspect of the 
process through which this programme is delivered, 
and it carries through the detox and aftercare 
phases. 
Although the doctor may have referred the 
client, the doctor’s role in the preparation phase 
is minimal, and limited to medical services. 
Interviews with doctors and Novas staff indicate 
that Novas staff only initiates contact with the GP 
about beginning the detox phase when a client 
meets the entry dose level criterion and the team 
has confidence in the client’s commitment to 
medical detox. A high level of transparency and 
open communication characterizes the relationship 
of team members to prescribing doctors. Key 
workers attend visits to doctors with clients on a 
regular basis. Indeed, interviews with staff, doctors, 
and clients indicate it is the rare occasion that a key 
worker does not attend the GP visit with the client. 
Information is shared in these meetings, which are 
led by the GP – client relationship. 
The Progression Routes Protocols require clients 
to provide a minimum of 14 consecutive days of drug 
diaries for the period leading up to the initiation 
of detox. In the Novas Community Detox, the drug 
diaries are integrated into the preparation phase, and 
are seen by the team as an important resource for 
really getting to know and understand the client and 
her or his needs. Clients and staff report that drug 
diaries usually extend substantially beyond 14 days. 
In interviews, staff members frequently referred 
to diary periods extending from four weeks to two 
or more months prior to the initial appointment 
with the GP. This elongated diary period ensures 
that the service user’s benzo use tapers at a rate 
that minimizes the risk of relapse, maximizes the 
client’s comfort with tapering, and builds the client’s 
confidence that she or he has the capability to 
successfully taper and ultimately completely detox. 
Longer and slower preparation phases seem to foster 
team members’ confidence in clients’ commitment 
to detox. Importantly, it also facilitates the team’s 
familiarity with the client and the client’s familiarity 
with the team. 
During the preparation phase a client meets a 
key worker for a minimum of an hour a week to 
review the drug diaries, and explore their support 
needs. Interagency care planning includes social 
services and family supports and structures that 
will support the client’s individual efforts toward 
tapering and relapse prevention. Each support 
plan is individualized to a particular client’s 
own resources and needs. The team explores the 
ecology, or context, of each client’s life and works 
to identify and re-establish positive supports. In 
interviews, both clients and staff described how the 
key workers work with the whole family where 
possible to strengthen supports that will support 
the client and prevent relapse. The team works 
holistically with clients during this period to link 
in with medical cards, social welfare, and other 
drugs supports such as NA. Many clients are at risk 
of homelessness, and the team works with them 
to obtain housing. The Novas CD team also refers 
clients’ families to the Respite House.
Importantly, the team works with clients at 
their pace and driven by client interests to replace 
benzodiazepines with other stress-reduction 
and coping resources like meditation and yoga. 
Recently the team has been able to put weekly 
classes in place at McGarry House, and clients 
avail of them. Clients are also linked into a local 
gym, and are encouraged to try out or resume 
activities that may help them deal with stress and 
cope with anxiety through other channels and 
build their capacity to do so while at the same time 
they reduce their benzodiazepine consumption. 
The respite house is availed of by client’s families, 
and this often helps reduce tensions and allow 
family members to come back together again. 
Respite House is a brief intervention for families 
of alcohol and drug misusers. At Respite House, 
expert members of staff provide psychosocial skills 
development (e.g., parenting, boundary setting), and 
complementary therapies (e.g., reflexology, massage 
and acupuncture). Respite House is a peaceful and 
therapeutic environment where family members 
may recover from the stresses of a loved one’s 
alcohol or drug misuse, and also learn new ways of 
coping with these stressors. 
The Novas CD team modulates the pace of the 
preparation phase to fit the needs of each client. 
The preparation phase may be as short as four 
weeks, but as long as six months. As long as a client 
engages with the team, the team engages with 
the client. The preparation phase continues for 
as long as necessary, with no time limit, until the 
client reaches a level of benzodiazepine use that 
meets the detox entry criteria. Once the client has 
achieved the entry criteria, contact with the GP is 
initiated. The team has established relationships 
with many GPs in the region; most GPs who serve 
this population are aware by now of the community 
detox. If a client’s GP has no prior experience with 
Novas CD, then the CD Coordinator introduces the 
project to the GP, explains the service, and provides 
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them with copies of the protocols and other 
relevant information. Often, however, at this stage, 
the GP is already familiar with the programme, and 
so the groundwork is already laid. If the client was 
referred by her or his GP, the team contacts that GP 
to share information about the client’s work during 
the preparation phase and their current benzo 
intake. In circumstances where the client may not 
have a GP, then the team works with the client 
during the preparation phase find a GP and begin to 
link in to her or his surgery.  
DETOXIFICATION
According to the Community Detox Protocols, 
this stage involves the service user reducing 
medication in line with a schedule agreed with 
the doctor. The key worker continues to provide 
care planning support and relapse prevention 
throughout the detoxification period. 
Interviews with doctors, clients, and team 
members indicate that the team effectively provides 
supports to both doctors and clients during this 
phase. Clients and team members described how 
the team members usually to always accompanies 
clients to their doctor visits on a weekly basis. 
Clients meet with their doctors regularly, at 
minimum every two weeks, but often on a weekly 
basis. In line with Progression Routes Protocols, 
daily dispensing is adhered to in the beginning 
phase of a detox, but as the client progresses, less 
frequent dispensing is regularly negotiated and 
agreed amongst the doctor, client, and team. 
The detox schedule is determined by the 
doctor in collaboration with the key worker and 
client. Team members report that doctors are 
often receptive to information provided to them 
in the protocols and from the team regarding the 
development of a client’s detox schedule. However, 
the extent to which the doctor is willing to 
negotiate the detox schedule with the client and 
modify the schedule in response to the client’s 
comfort level is variable. Clients and key workers 
described some experiences with doctors who 
rigidly apply a detox schedule from beginning to 
end, while other doctors work with the client to 
modulate the pace according to client comfort. From 
client and team member interviews, it appears that 
the degree to which the doctor attunes to a client’s 
comfort has an effect on the client’s experience 
of the detox. Interviews with clients indicate that 
they respond better to longer detox schedules than 
shorter detox schedules. Clients’ descriptions of 
their detox experiences indicated less satisfaction 
with doctors who adhered to a rigid schedule 
of detox than with doctors who were willing to 
lengthen the detox period and modulate the pace in 
response to clients’ comfort. 
During the detox phase, in line with Progression 
Routes Protocols, an additional weekly meeting 
occurs between client and key worker for care 
planning support and relapse prevention. These 
weekly client-key worker meetings sometimes 
increase in frequency in response to client support 
needs. Interviews with team members and clients 
illustrated the ways in which the team modulates 
the intensity and frequency of supports in response 
to client needs and interests. For example, during 
stressful life events or transitions, the team 
members intensify supports provided to clients. 
As a consequence, clients report a high degree of 
confidence that the team is “always there for them” 
and can be called on at any time. The feeling of 
security and dependability that clients describe and 
that team members deliberately cultivate seems to 
be a key ingredient in clients’ successful detox and 
the prevention of relapse.  
The team is highly committed to supporting 
clients through the detox phase and will continue 
to support the client through periods of missed 
appointments, relapses, and challenging behaviours. 
However, the team also adheres closely to the 
Progression Routes Protocol guidelines concerning 
missed appointments. Key workers attempt to 
reengage clients who miss appointments without 
cancelling and rescheduling, but those who miss 
two or more appointments without reason and 
without rescheduling are discharged from the 
programme. Case notes and interviews with team 
members indicate that the team communicates to 
clients that the door to reengagement is always 
open to them when they are ready to try detox 
again. Case file review, interviews with team 
members and with clients indicate that clients do, in 
fact, return to the team and try again. 
AFTERCARE
According to the protocols, the key worker 
and service user continue to engage in weekly 
care planning and relapse prevention supports 
for six months following completion of the detox. 
Interviews with team members and clients indicate 
that all clients receive a minimum of six months 
aftercare planning and relapse prevention supports. 
This phase is open-ended, so that clients who need 
a longer aftercare phase will receive it, and those 
who need to return to aftercare for additional 
support may do so. The team members talked about 
the importance of building personal, interpersonal, 
and community supports during preparation and 
detox phases so that when the client reaches the 
aftercare phase, the detox programme can become a 
smaller and smaller part of an increasingly dynamic 
community within which the client is integrated. 
The creation of a “wheel of supports” (see chapter 
6) is an important aspect of this team’s approach 
to support planning. According to the team, if the 
work is done during the preparation and detox 
phases, then then other supports take over from 
Novas, so that both Novas and the person’s drug 
misuse, can fade into the background and become a 
minor aspect of the client’s life and identity. 
In interviews, clients talked about the aftercare 
phase as an important incentive to completing the 
detox phase. Clients who were interviewed for this 
evaluation expressed how much they valued the 
team’s continued support. One client in particular, 
who was in the detox phase at the time of interview, 
repeatedly referred to aftercare as a valued 
component of the programme, and the she looked 
forward to reaching that phase of the programme. 
DISENGAGEMENT
According to the Progression Routes Community 
Detox Protocols, disengagement refers to the point 
in time when a service user ceases to engage with 
the team. Disengagement occurs when clients miss 
two or more meetings with the key worker or if 
the client is believed by either the doctor or the 
key worker to be misusing substances during the 
detoxification period. 
Interviews with team members, clients, and 
doctors indicate that the team closely follows 
the Progression Routes protocol guidelines for 
disengagement. The team does not impose any 
additional requirements on clients that result 
in disengagement for reasons other than those 
stated in the protocols. Interviews with clients 
indicate that they understand that these are the 
only conditions under which the team will initiate 
disengagement. Clients expressed a great deal of 
trust in the team, in that they have the confidence 
that they can share any substance-related or –
unrelated problem, such as legal, social, medical, or 
psychological with the team and the team will not 
remove or restrict any of the programme services. 
This level of trust and transparency between 
client and team appears to be a vital aspect of both 
support planning and relapse prevention, one that is 
mutually highly valued by both the team members 
and the clients. 
Case notes review, interviews with team 
members, clients, and doctors indicate that 
when disengagement occurs, it is typically when 
clients’ miss appointments without reason or 
reschedule. Occasionally, clients engage in drug 
misuse that triggers disengagement, but the 
team, and sometimes the doctors, are willing to 
tolerate relapses and polysubstance use when 
clients are committed but struggling. Open lines of 
communication between doctor and key worker, 
and between key worker and client, facilitate 
attempts to address the client’s behaviours and 
avoid disengagement. In some cases, however, the 
client’s behaviour warrants a discontinuation 
of the detox phase. When this occurs, the team 
communicates an open-door policy to the client so 
that the client may re-engage when she or he is 
ready to try another detox. 
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According to the Community Detox Protocols, 
the minimal standards for delivery community 
detox are: 
• Interagency care planning: support planning that 
takes into account all factors that may negatively 
impact on ability to engage in a successful detox 
such as housing, family matters, meaningful use 
of time and social supports;  
• Relapse prevention: structured sessions aimed to 
provide clients with skills and knowledge base 
around drug use, risk, and relapse; 
• Medical supports: regular medical appointments. 
Doctor agrees to engage in interagency 
communication with the key worker about client 
progress and changes to initial detox schedule or 
care plan. 
The findings from this fidelity evaluation 
indicate that the Novas delivers community detox 
with a high degree of fidelity to the Progression 
Routes Protocols and certainly meets and exceeds 
the minimal standards outlined above. The 
team and its management have made a number 
of important adaptations to the delivery of the 
protocols, which seem to have improved the model 
and strengthened its delivery. Some of the key 
adaptations that appear to have contributed to the 
successes of this programme are: 
1. Expansion of the role of the broker in terms of 
hours and responsibilities;
2. Development of a highly skilled, highly 
competent team of keyworkers who support 
clients and doctors in the delivery of the 
community detox protocols; 
3. Focus on in-house keyworker support to clients 
and doctors rather than service agreements with 
other regional agencies; 
4. Systematic and strategic development of in-
house resources for clients to avail and support 
their preparation for detox and for relapse 
prevention such as acupressure, meditation, and 
yoga. 
Taken together, these adaptations clearly appear 
to have contributed to the programme’s reach 
and intensity. There is no evidence from case 
note review, from interviews with stakeholders, 
team members, clients, or doctors that the Novas 
implementation of the Progression Routes 
community detox protocols has in any way drifted 
away from the fundamental intention to create 
opportunities for individuals in the Midwest 
Region to avail of community-based detox. In fact, 
the adaptations observed in this programme only 
strengthen the model and enhance the team’s 
ability to provide clients with supports from highly 
qualified experts in addiction and recovery while 
they undertake supervised medical detox in their 
own communities. In the following chapters, 
evidence for key outcomes of the programme are 
presented. 
REFERENCES
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The team recorded a total of 335 
contacts between 1 May 2012 and 
24 June 2015. From these contacts, 
132 new cases were opened. 
Of these cases, 73 (55.7%) were 
still open, while 58 (44.3%) had 
disengaged from the programme at 
the time the data were obtained (26 
August, 2015).1 The following client 
information was obtained from 
analysis of these 132 unique cases.
Client locations were spread across the Midwest 
region. Most were located in Limerick City (n = 
59, 45.4%) or Limerick County (n = 33, 25.4%), but 
a notable number were located in County Clare 
(n = 18, 13.6%) and North Tipperary (n = 19, 14.6%).  
Referrals came from a number of sources: self-
referral (19.5%), LDAS (15.8%), or GP (12.0%). Answers 
to the question “how did you hear about the 
1 Numbers of participants do not always add up to 132 and 
percentages do not always add up to 100% because of missing 
data. 
service?” were recorded for 26 clients. Sixty percent 
of these 26 clients reported they heard about Novas 
CD from either their GP or another drug service. 
Data on duration of engagement with Novas 
CD was available for 127 clients. For these 127 
clients, the average length of engagement with 
the programme was 38.5 weeks, with a range from 
1 week to 3.25 years. For engaged clients (n = 57), 
the average length of contact was 41.34 weeks (9 
months), with a range from 3.86 weeks to 3.25 years. 
For disengaged clients (n = 69), the average length 
of engagement was 36.37 weeks (8.37 months), 
with a range from 1 week to 2.14 years. Neither age, 
sex, nor whether or not the client had dependents 
predicted duration of contact. 
Information on the phase of treatment in 
which disengagement occurred was available for 
70 clients. Most (70.4%) clients disengaged during 
the preparation phase, while only 4.3% (3 clients) 
disengaged during brokering, and 5.7% (4 clients) 
disengaged during detox. One in ten (7 clients) 
disengaged when after care was completed, and 
another 8.6% (6 clients) disengaged during aftercare. 
This indicates that 18.5% of clients for whom we 
have complete data stayed engaged until they 
completed detox and at least some aftercare. 
Further information about disengagement is 
available for 56 clients. Of these 56 clients who 
disengaged from services, 89% (47) disengaged 
Client Descriptions
& Client Outcomes
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before detox started, and 9 disengaged after detox 
started. Of those who disengaged before detox 
started, 36% did not meet the criteria and did not 
want to begin detox; 32% met the criteria, but did 
not want to continue; and 30% met the criteria for 
detox but could not continue for other factors. Of 
the nine clients who discontinued after detox was 
initiated, only one availed of support but continued 
to use, 3 missed two or more appointments, and 
five disengaged for another reason.  Most clients 
(92.7%) ceased contact with their keyworker after 
disengagement. 
Average client age at first contact was 31.28, 
with a range from 18 to 65, and men and women 
were not different from one another in age at 
engagement. Eighty-one (61.4%) clients were male, 
and 51 (38.6%) were female. All clients except one 
were Irish citizens; the exception was from Poland. 
Information on education was not collected. Most 
participants were unemployed (n = 108, 81.8%), 
while only 8 (8.8%) were employed either part- 
or full-time.  Almost half of clients (47%) had at 
least one kind of ongoing legal problem. The most 
common criminal justice issues were probation (12%) 
or pending charges (11%). 
Although most clients were unemployed, only 
about 29% reported that they receive a social 
welfare payment. Females were more likely to 
report receiving a social welfare payment (29.4%) 
than males (17.3%) (χ2 = 5.52, p = .019). Most clients 
lived in the family home (n = 43, 31.6%) or rented 
or owned their own home (n = 35, 25.7%), with the 
rest lived either in Local Authority housing (13.2%), 
hostels (8.8%), or with friends or relatives (8.1%). 
About 10% of clients were at risk of eviction, and 
18% had experienced an acute housing crisis in the 
past 30 days. 
Most participants (61%) reported that they did 
have dependents. Women were more likely (78.3%) 
than men (55.3%) to say they had dependents to 
care for (χ2 = 4.59, p = .03). The total number of 
dependents each participant reported ranged from 
0 to 9, with an average of 1.55 dependents per client. 
Men reported an average of 1.39 dependents, and 
women reported an average of 1.83 dependents, 
but the difference was not significant. The number 
of dependents under age 18 ranged from 0 to 7, 
with an average of 1.26 per client. Men reported an 
average of 1.04 dependents under 18 and women 
reported an average of 1.59 dependents; this 
difference was significant (t = -1.99, p = .049). Most 
participants (60.3%) were not single parents, and 
women were much more likely to report that they 
were a single parent (χ2 = 20.64, p < .001). 
PHYSICAL HEALTH 
Data on subjective physical health status were 
available for 84 clients. On a scale from 0 = poor to 
20 = good, average client rating of physical health 
status was 9.53 (slightly below the midpoint), with a 
standard deviation of 5.20 and a range from 0 to 20. 
PSYCHOLOGICAL AND PSYCHIATRIC 
INFORMATION 
Of the 92 clients for whom we have data, 57.6% 
reported no history of psychiatric symptoms. The 
most frequently reported psychiatric problems 
besides anxiety were depressive symptoms: 26% of 
clients reported problems with unipolar depression 
or depression mixed with anxiety, and/or suicidal 
thoughts and/or suicide attempts. Other kinds of 
psychiatric problems such as psychotic disorders and 
bipolar disorder were reported at much lower rates. 
Data on subjective psychological health status 
were available for 84 clients. Clients rated their 
psychological health on a scale from 0 = poor to 20 
= good. The average score was 7.27, with a standard 
deviation of 4.18 and a range from 0 to 18. The 
sample average was significantly lower than the 
midpoint of the scale (10) (t = -5.97, p < .0001).  Clients 
were also asked to rate their quality of life on the 
same 20 point scale. The average score was 8.37, 
with a standard deviation of 5.37 and a range from 0 
to 20. The sample’s average quality of life score was 
significantly lower than the scale midpoint (10) (t = 
-2.73, p < .008). 
REPORTED DRUG PREFERENCES AND DRUG USE 
AT INITIAL CONTACT
Upon acceptance into the programme, clients 
are asked to rank order three drugs of choice and to 
report their current use rates. These are presented 
in Tables 2 and 3. As can be seen in Table 2, 
benzodiazepines were the large majority of clients’ 
drug of choice, with 65.4% ranking them as their 
top preference, and 91.1% ranking them in the top 
DRUG 1st PREFERENCE 2nd PREFERENCE 3rd PREFERENCE TOTAL
% COUNT % COUNT % COUNT    %
BENZODIAZEPINES 65.4 89 22.8 31 2.9 4 91.1
ALCOHOL 3.4 5 8.8 12 4.4 6 16.6
CANNABIS 5.1 7 20.6 28 2.9 4 28.6
HEROIN 12.5 17 11.0 15 - 0 23.5
METHADONE - 0 4.4 6 - 0 4.4
SLEEPING TABLETS 2.9 4 <1.0 1 <1.0 1 7.6
COCAINE 2.9 4 3.7 5 <1.0 1 7.6
AMPHETAMINES <1.0 1 1.5 2 1.5 2 4.0
MORPHINE/ANALGESICS 2.2 3 1.0 < 1 <1.0 1 4.0
Clients are also asked to report current drug 
use type, amount, and frequency. As can be seen 
in Table 3, benzodiazepines are the most used drug 
by Novas CD clients. Novas Community Detox 
was the first drug treatment for 27% of clients. The 
other 75% of clients reported previously engaging 
in one or more drug treatment services. Previous 
engagement in methadone treatment, counselling, 
three. Cannabis was listed in the top three by 28.6% 
of clients, and heroin was listed in the top three by 
23.5% of clients. All other categories of drugs and 
alcohol were reported much less frequently.
and Narcotics Anonymous were reported by 30% of 
clients. Sixteen percent had entered inpatient detox, 
and six percent had engaged in outpatient detox. 
Nine percent had engaged in needle exchange. 
Almost one-third (31%) of clients are also currently 
on methadone maintenance. Reported dosage 
ranged from 10 to 115 milligrams (average = 64, 
standard deviation = 28). 
TABLE 2. DRUG OF CHOICE
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TABLE 3. DRUG USE AT INTAKE
BENZODIAZEPINES
0 TO 5 6 TO 10 11+ DAILY 2 TO 6 DAYS 
PER WEEK
WEEKLY MONTHLY
NUMBER OF CLIENTS 35 21 40 91 2 3 0
% PERCENT (OF 132) 26.5 15.9 30.30 68.94 1.5 2.27 0
HEROIN
<1 BAG 1-3 BAGS 4-6 BAGS DAILY 2 TO 6 DAYS 
PER WEEK
WEEKLY MONTHLY
NUMBER OF CLIENTS 3 10 1 10 1 4 2
% PERCENT (OF 132) 2.27 7.58 <1.0 7.58 <1.0 3.03 1.51
METHADONE
NUMBER OF 
CLIENTS
% PERCENT (OF 132) MINIMUM MAXIMUM AVERAGE STANDARD DEVIATION DAILY
21 15.91 35 115 76.79 19.28 22
ALCOHOL
0-10 
UNITS
11-20 UNITS 21 + UNITS DAILY 2 TO 6 DAYS 
PER WEEK
WEEKLY MONTHLY
NUMBER OF CLIENTS 2 3 4 4 6 2 0
% PERCENT (OF 132) 1.5 2.27 3.03 3.03 4.54 1.51 0
CANNABIS
1-3 
SPLIFFS
4-6 SPLIFFS 7-9 SPLIFFS 10+ SPLIFFS DAILY
NUMBER OF CLIENTS 5 5 4 3 17
% PERCENT (OF 132) 3.78 3.78 3.03 2.27 12.88
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Key Features and Qualities 
of Service Delivery
05
Findings regarding the key features 
and quality of service delivery 
are described in this chapter. 
These findings were derived from 
transcripts and notes obtained from 
interviews with Key Informants: 
team members, service users, 
doctors, and key stakeholders. 
Findings are organized into eleven 
topics. In combination with the 
fidelity assessment and quantitative 
client outcomes, the findings 
presented in this chapter build 
toward the development plan and 
recommendations presented in the 
final chapter of this report. 
All Key Informants indicated that they believe 
that the service is competently delivered to the 
intended population and that it is a needed service 
that fills an important gap in the continuum of care. 
Further, the service is appraised not only to adhere 
to the Progression Routes Protocols, but also to go 
beyond the Protocols in its implementation of a fully 
staffed team. Key Informants described the team as 
highly committed to delivering the protocols. For 
example, one Key Informant referred to the Novas 
programme as one of the few programmes included 
in the national pilot that was really committed 
to delivering community detox according to the 
protocols. Key Informants listed a number of ways 
in which the Novas CD Coordinator demonstrated 
this commitment, including: attendance at Dublin 
broker meetings, diligent engagement with the 
community, successful and broad engagement 
with services, doctors, and stakeholders. One Key 
Informant described Novas as seeing “the value 
of the community detox programme, dedicating 
resources to it, and using the structure well. It was the 
gold standard for delivering community detox.”
Virtually all Key Informants described the 
team as passionate, skilled, and professional in 
General Appraisals of the Novas 
Community Detox Programme
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Key Informants appraised the Novas community 
detox to have a good governance structure and 
to have a range of competencies that are valuable 
in the delivery of community detox, all of which 
position this team as particularly qualified to 
operate this service in the Midwest. One Key 
Informant said: “…homelessness was their [Novas’] 
priority but they really have branched and taken on 
board and developed that experience and they’ve got 
the right staff on board, the likes of Dan who has that 
expertise. I would have had concerns if it was a very 
much homeless-driven mentality within the service…
but it’s not. It’s homelessness, drugs, early school 
leaving, bullying; you know, they’re very au fait with 
the holistic approach, so that appeals to me: the fact 
that they’re very community focused, the fact that 
they’re working well with other services, the fact that 
they work well with ourselves.”
Because drugs services need to work together 
to effectively deliver the full range of services 
represented in the continuum, it was important 
that Novas CD developed positive relations with 
other drug services in the region. The Novas CD 
is viewed by Key Informants as a vital step in the 
continuum of care in the Midwest Region. One Key 
Informant described Novas Community Detox as 
having a “very important role, [a] hugely important 
role. ... Community detox is probably their first port of 
call, as opposed to residential, ‘cause a lot of the cohort 
that avail of low threshold service, they wouldn’t be 
referring into residential largely speaking, they’d be 
[referring to] Coolmine, so community detox, so their 
relationship is key.” 
One Key Informant who works in pre-treatment 
services for a rehab-only programme said that 
Novas CD runs a very good programme that 
provides an important complement to his service. 
This Key Informant values being able to refer clients 
to a detox programme where the workers follow 
effective protocols. This Key Informant observed 
that when doctors work alone they can detox their 
patients too quickly, and that Novas CD helps slow 
this process down. He said Novas CD also helps the 
clients understand that a slow detox is a better and 
more effective detox because it reduces risk and 
keeps the person engaged rather than get frustrated 
because they want a quick fix. This point is returned 
to in a later section of this chapter focused on the 
team’s relationships with doctors. 
Not only does Novas Community Detox have an 
important role in the delivery of drugs services in 
Limerick City, they also contribute to drugs services 
in the entire region. They contribute to drop-in 
services in County Clare and in North Tipperary. 
They are also a regular participant in Dromin House 
Day Hospital in their dual diagnosis treatment 
pilot, an aspect of the services they deliver which 
is described in a subsequent section of this chapter. 
Novas’ contribution to regional drugs services is 
highly valued by key stakeholders who said it is 
“fantastic” that such a small service makes such a 
large contribution to this sprawling geographical 
region, which is difficult to cover and provide 
enough services to meet the needs of the region’s 
residents. 
However, early days were accompanied by 
a rocky start and some interagency challenges. 
For example, in the early days, Novas CD had to 
convince other treatment services to send referrals 
to them. Over time, however, Novas leadership 
worked out effective interagency relationships, and 
tensions dissipated. Now, it seems that Novas CD’s 
place in the continuum of care is well-established 
and appraised to complement rehab and other types 
of inpatient or residential treatment. 
Key Informants’ impressions of team 
management were very positive. The CD 
Coordinator was described as “having a good handle 
on it in terms of his team and how it’s running, as 
having “good ideas in terms of developing the project 
[and] at the same time making it sustainable….I 
have a lot of faith in Dan in his experience and so on. 
So that’s what I’m saying about Novas employing 
the right people, um, and then in terms of reading 
from the reports, from a governance perspective 
the boxes seem to be ticked, and I know that Novas 
is very strong in that because of their own line of 
work anyway in the homeless area, so they adhere 
to the QuAds framework, they adhere broadly to 
the community detox framework, um and then they 
adhere to the criteria that’s laid out in the Service Level 
Agreement, so from that perspective I don’t see any 
issues, you know.”
  
ADHERENCE AND COMMITMENT TO 
PROTOCOLS
Although the team is appraised to have excellent 
governance and oversight, their approach to 
community detox varies in some important ways 
from the National Steering Group, and some Key 
Informants raised this distinction to illustrate how 
the team responds to oversight challenges arising 
from differences in approach to detox. Adaptations 
to the broker and key worker roles were questioned 
by some individuals involved in the National 
Steering Group who developed the protocols and 
had oversight of the national pilot. The fact that 
Key Informants from the national level of oversight 
praised the work done by the CD Coordinator in 
the blended broker-keyworker role indicates that 
the CD Coordinator effectively negotiates these 
differences in approach.
Novas’ funders were happy with and supported 
these adaptations and expansions. In fact, Key 
Informants described these adaptations as some 
of the keys to the team’s successes. Indeed, taken 
together, findings from this evaluation suggest 
that the adaptations to keyworker and broker 
roles enhance the delivery of community detox, 
and the Midwest Region’s decision to fully fund a 
community detox and staff it beyond the minimal 
standards as laid out in the protocols was wise, 
showed foresight, creativity, and resourcefulness. 
Team Governance and Oversight
Relations with other Drug Services in the Regiontheir interactions with key stakeholders, doctors, 
and clients. One Key Informant described it this 
way: “Maybe it took a bit of time to get their name 
out there but then they did. They did that very well. I 
mean that in the broader context, I mean the strengths 
were getting in with the GPs and so on so quickly. 
Um, strengths are the personnel involved, strengths 
are their ethical approach, their community base, 
[and] good governance structure, [both] clinical and 
operational.” 
Some Key Informants complimented the team on 
the extensive development and self-learning they 
have accomplished since initiating the programme. 
For example, one Key Informant said: “Yeah I mean 
when, when the project started we were all finding our 
feet a little bit. Novas were trying it out, we weren’t 
sure about this project, but as time has gone on we’re 
almost learning as much from the project as- as 
anything, ‘cause it’s new, it’s different, it’s never been 
done before.”
Clinical Governance and Management
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COST-EFFECTIVENESS AND COST-BENEFIT 
APPRAISALS
Key Informants with insight into financial 
aspects of the programme indicated that they 
believe the programme represents a good value 
for money. For example, when asked whether the 
Novas CD gave a good return on the investment, 
one interviewee said: I [am] well-placed to answer 
that. [] I see the [] operational reports and [] financial 
breakdown [], and to be fair to Novas, and I’d say this 
for both their projects, respite as well, very much so, 
very much so.
Not only do Key Informants report that the 
community detox yields an important return 
on the investment, their impression is that the 
programme is highly cost-effective, in that it is 
much less expensive than residential detox, yet 
still produces positive outcomes for service users 
and their communities. One Key Informant said: 
“If we were to run a fully- fledged residential detox 
facility in the Midwest that would be our budget 
wiped, so that would be all the other projects: The 
community substance misuse team, Ana Liffey, the 
respite house with Novas, Clare Youth Service project, 
all these things would go because we’d have to put all 
our money into a detox facility. There was massive 
pressure from the community level four or five years 
ago and ourselves and the HSE to set up a detox 
facility um, hence the community detox protocols 
from Ana Liffey [operated by Novas CD], they 
were welcomed, it was an alternative, and it seems 
to be working quite well, and while I think it seems 
to work well and this is my opinion, from speaking 
to people is that it is community-based and it goes 
back to that piece of meeting people where they’re 
at. Treatment services aren’t for everyone [because] 
they’re expensive, they’ve waiting lists et cetera. All 
these things are bypassed with the community detox 
approach.” 
Importantly, community detox is not only less 
expensive and more accessible to a wider population 
than residential detox, it also offers an approach 
to detox that has a particular set of advantages. 
Novas community detox offers the service user 
an opportunity to detox within the community, 
during which time they can develop supports and 
personal skills in vivo that will contribute to relapse 
prevention. As one Key Informant said, when a 
service user is “off somewhere in a treatment centre 
where everything’s rosy, everything is lovely, you’re 
away from the world for four or five weeks, … and 
then you’re [discharged], you’re back you’re back to 
the cycle - yeah back to the cycle of reality”, without 
having necessarily learned the skills you need to 
deal with that reality. 
TEAM COMPETENCIES AND TEAM 
FUNCTIONING
The team’s community-based approach meshes 
well with Key Stakeholders’ priorities for the 
delivery of drugs services in the Midwest Region. 
For example, one Key Informant said: “projects like 
this [], the fact that they’re in communities, they’re 
listening to people on the ground, they’re actually 
clued into what’s going on- on the ground, that’s what 
really appeals to me about this project you know []. I 
see it with my own two eyes, because the relationships 
they have, even in McGarry you know, because 
they’re dealing with clients every day of the week, they 
know how to relate to [clients] ... that’s a major benefit 
for the community detox project that they have that 
hands-on everyday experience.” 
As described in Chapter 4, and as illustrated in 
the Client Outcomes section of this chapter, the 
team takes a family-centred approach to delivering 
the community detox programme. This approach 
is consistent with Key Stakeholders’ visions for the 
delivery of drugs services in the Midwest region: 
“Family is a big factor within our approach ‘cause 
if you can get the family unit right, you get a lot of 
the other issues close to right, maybe not always, but 
family is a big factor. [] And to be fair, the community 
detox is now very much built in and bedded in, in that 
broader, that broader plan, you know.”
 The team’s efforts to build effective support 
structures in the community that reach beyond 
clients’ families are also congruent with key 
stakeholders’ priorities for drugs services in the 
region. One Key Informant said: “support structure 
is key as well, so that when [clients] do go back to 
living at home and they’re in that cycle and they’re 
surrounded by Johnny, Mary, and whoever is using, 
so they have supports to get away from that. And 
it’s like coming out of prison, same thing, that we are 
trying to develop new systems, programs that will 
KEY STAKEHOLDERS’ IMPRESSIONS OF 
THE PROGRAMME’S OUTREACH TO AND 
RELATIONSHIPS WITH GPS
The team has established a reputation for 
working very well with doctors in the region, 
providing them with effective supports believed 
to be important to reducing risk and to relapse 
prevention during a benzodiazepine detox. One 
Key Informant said: “The thing I’ve been impressed 
with is the amount of GPs they got to, to inform them 
of the service, and the amount of GPs they’ve got on 
board has been really impressive. Some of those GPs 
are in it now three four years… which, so I’ve been 
very impressed with that.” As described in more 
detail in the subsequent section on other drugs’ 
support people getting out of that cycle that they want 
to get out of, so they’ve gone through their detox and 
their ready to go back ìn the environment they were 
in when they first left. That’s a massive challenge, but 
it’s something we’re trying to develop.” As described 
in Chapter 4, the team works with clients to develop 
individualized, client-driven support plans to 
equip them to live within the environments where 
they began to misuse drugs. Because most clients 
will not be able to leave these environments, it is 
important that they become equipped to effectively 
negotiate challenges they will face and, hopefully, 
prevent relapse. The team’s approaches to helping 
build clients’ support services in the community are 
described in a subsequent section of this chapter, 
and the team’s ambitions to enhance and grow 
their capacity to deliver this aspect of their service 
are described in the final chapter of this report. 
The important point here is that the team delivers 
a service that is congruent with key stakeholders’ 
priorities, and they hope to build their capacity in 
these areas.  
services relationships with the Novas CD, one Key 
Informant described his impression that the Novas 
CD functions as an important “safety valve” to GPs, 
slowing down the detox process through the use of 
the protocol stages and guidelines.  
DOCTORS’ EXPERIENCES AND IMPRESSIONS OF 
THE PROGRAMME
With one exception, every doctor who was 
reached for comment on this programme had 
very positive appraisals, appreciated the supports 
provided by the team, and respected the team for 
their competence, skills, and expertise in the area of 
drugs services. Doctors appreciated the presence of 
team members at meetings with service users. They 
Community Supports and System of Supports are Congruent  
with Funder Priorities
Relationships with General Practitioners
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described the ways in which the support provided 
by the team afforded them a level of confidence that 
they could safely deliver a community-based detox. 
Doctors also appreciated the complementarity of 
the team’s expertise to their own medical expertise. 
One doctor said, “I felt empowered by the counsellor 
who was also advising. It was a good experience”. 
Describing a difficult situation with a service user, 
one doctor said: “[The Keyworker] seemed to know his 
stuff, and he was doing his best to try and uh, and he 
was well able to, you know, rules were being broken 
by the patient, and he [the keyworker] was well able to 
stand up and say, “this isn’t good”.’ 
The keyworker who worked with this client 
had similarly positive reflections on the experience 
of working with this doctor to address this 
client’s challenging behaviours. This keyworker 
described how the service user was believed to 
be supplementing his prescribed dosage with 
benzos from another source, and had even forged 
a prescription. “[The client] denied it and then his 
behaviour became not equal with the expected 
behaviour. He wasn’t changing sufficient to the period 
of time he was on the detox, so it became apparent that 
something was amiss. So then he, without ever having 
really adhered to them in the first, place, he forged 
a prescription so we agreed with [the doctor] it was 
there was no point in continuing. So we stopped at that 
stage and I went with the client to [the doctor] and [the 
doctor] told him and I told him...So it was a difficult 
case, but nevertheless I felt that, while the beginning 
might not have been ideal, I felt that the success came 
at the end when both, two of the three parties worked 
together, and to me that was the success and that 
copper-fastened the need always to adhere to the 
protocols.”
Speaking in more general terms about the value 
of working with the Novas CD, one doctor said 
he would not attempt to detox a client without 
the support of the team. The team’s dedication 
to attending GP appointments with clients is 
appreciated by this doctor, who said the presence 
of keyworkers with clients is absolutely necessary 
because their presence assures him that there is 
someone to check in with the patient and provide 
counselling. His impression is that keyworkers are 
vital to the detox process because “you can’t just 
leave people on their own when they are this severely 
addicted to benzos and trying to detox from them. 
They have poor coping skills and don’t know how 
to manage stress. If the CD can develop methods of 
working with clients to help them build non-drug 
strategies to deal with stress, they will have addressed 
the core issue of addiction. The team helps create a 
situation where you know where you stand with a 
patient and helps you trust a patient. He values that 
very much – he doesn’t have the time to spend with a 
patient or the skills to do the counselling.” He added 
further that although some of his GP colleagues 
do attempt detoxes without the support of a detox 
keyworker, he thinks this is unwise. He worries 
without the support of the detox team that GPs risk 
becoming a means to subsidize a patient’s habit. 
For doctors who are sceptical about the 
effectiveness of detox, the community detox team is a 
particularly important resource. One doctor said the 
counselling provided to service users by Novas CD 
was “exceptionally important” to a successful detox 
because “the only chance’ a service user has to succeed 
is with counselling and supports. Novas offers doctors 
a level of confidence in clients and removes or reduces 
worries that the client is coming in asking for detox when 
they run out of money and can’t access on streets or 
to supplement what they are getting on streets.” This 
doctor said he finds it “really depressing” when he tries 
to help someone detox and then realizes they are just 
using the detox as a pretence to supplement their drug 
sources. Now, he won’t do detox without the back up 
of drugs services. 
One doctor expressed his appreciation for the 
time that Novas CD frees up for him in his practice, 
because the supports that detoxing patients need 
are extensive and time consuming: “yeah, well, you 
know, we’re all on a team and I don’t expect to be able 
to detox people or counsel people off medication or [] 
whatever illicit drugs like that without the counselling, 
that sort of thing...[It’s okay, but it’s] time consuming, 
you know, not exactly... we’re running a business here, 
and it’s not exactly conducive to operating a successful 
business, putting all that time into one person”. 
Only one doctor expressed any sort of 
frustration or disappointment in her experience of 
working with Novas CD. This doctor, who said she 
had worked with two or three clients, described one 
of the clients as “very aggressive and problematic”. 
When the client missed appointments and Novas 
disengaged with the patient, the patient continued 
to show up at her office demanding prescriptions. 
This doctor said she felt unsupported by Novas 
and was left with the impression that Novas only 
works with easy clients, not clients who are not 
able to engage with the programme. This singular 
negative experience is clearly the exception to 
the rule because the preponderance of evidence 
from case notes, team interviews, key stakeholder 
interviews, and service user interviews indicates 
that the team works with individuals with the full 
range of support needs and challenging behaviours. 
However, this doctor’s impressions do highlight the 
challenges of negotiating the three-way relationship 
between service user, keyworker, and client, and 
the team might consider the development of best 
practices guidelines for how to prevent, or minimize 
the potential for this situation to emerge.        
And finally, despite the team’s best efforts to 
engage doctors and encourage them to deliver 
a community-based detox, some doctors simply 
will not be interested or convinced that it’s a 
worthwhile endeavour. The team has worked 
with some GPs who have very little experience 
with detox and have low levels of confidence that 
a patient can be successfully detoxed. For example, 
one doctor said: “I’m still a little bit, ‘what’s the point 
of it all’, you know, in the end you know...So you know, 
I’m- I’m- I’m not as a GP not totally mad about the 
whole experience. I don’t really want to get involved 
with patients who are drug addicted. Maybe that’s 
a reflection of my weakness and my ability to treat 
it. Not sure. It’s a reflection of the patient themselves 
[who] are very difficult, you know? Are they fixable, 
really? That is the question.”  
 Negotiating relationships with GPs is sometimes 
challenging for the team, who described both 
positive and negative experiences with GPs over 
the years. One keyworker said: “... by and large 
all these experiences have been positive and- and I 
think the more doctors realized that we are present 
and- and that were there every week, and that we 
are, I think we’re all delicate about our suggestions to 
them...” However, keyworkers did describe doctors’ 
“bedside manner” in variable terms. One keyworker 
contrasted experiences with GPs this way: “One 
doctor said at the start of it, he said, I’m giving you a 
detox [for] a few weeks. That’s it. Take it or leave it, 
I’m sick of you!” You know those this sort of stuff - 
whereas another doctor will encourage clients and 
say things like “come on man, you can do it, you can 
do this!” A doctor’s approach to his or her patient is 
an important aspect of client’s support and overall 
experience of the community detox programme. 
Poor bedside manner can create challenges for the 
team and client, in that it discourages clients and 
makes the keyworkers’ job supporting, encouraging, 
and motivating clients that much more difficult. 
Poor bedside manner can negatively affect the 
team members, too. For example, one keyworker 
said, “there’s one GP that comes to mind; he puts the 
fear of God inside of myself. What’s it like for a client? 
Because you just feel you feel, I’ve walked out of his 
surgery feeling like I was something he brought in 
on the heel of his shoe.”  This is important because 
the client and keyworkers’ experiences of the 
doctor, and the doctors’ approach to community 
detox, influence both the quality of the client’s 
experience and the quality of the keyworker’s work 
environment. 
CLIENTS’ EXPERIENCES OF DOCTORS
Interviews with clients indicated their 
experiences with doctors were less positive than 
their experiences with the team. Common to these 
stories were clients’ experiences of doctors’ rigid 
adherence to tapering schedules without much 
apparent concern for clients’ comfort. One client 
said of her doctor: “she listened, but she wasn’t flexible 
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with the medication. She tried to cut me from four 
milligrams straight to two, and I was trying to explain 
to her that’s not going to work with me... to be honest 
I wasn’t ready to come off medication but she just 
cut me off medication and I got so sick from them 
I didn’t go back to her... yeah,  to be honest I should 
have done with another few weeks cause I’m still not 
sleeping enough and my weight then is up...Yeah I just 
quit my medication and I didn’t go back to her.” This 
example illustrates some of the challenges the team 
faces in delivering a safe community detox, and is 
consistent with other Key Informants’ descriptions 
of some GPs as wanting to deliver detox to their 
patients too quickly, and with team members’ 
earlier descriptions of GPs as inflexibly offering “a 
few weeks of detox, take it or leave it”. Importantly, 
in the Progression Routes protocols, doctors are 
advised to take detox very slowly, but interviews 
with doctors revealed that their familiarity with 
the details of the protocols is quite variable and 
probably on average, quite superficial. Novas 
community detox team members work to slow the 
process, but they are not always able to influence 
the doctors’ preference regarding the speed with 
which the detox is delivered.
One client described how the tenor of her 
relationship to her doctor changed after she entered 
and completed detox, to the point where she 
chose to change doctors. She said, “Well, I’m with 
a different GP now, ‘cause after the detox I just like, 
they were just really funny with me like, if I went if I 
was in pain, ‘cause I suffer a lot with UTIs. They kind 
of wouldn›t give you any pain killers or you know, 
over your history, which I completely understand, 
but because I did the program I kind of felt let down 
that they didn›t trust me, and it was the same with 
my partner. They wouldn’t give him any in case I was 
going to take them, and I- they were just kind of a bit 
standoffish, so I left. But during the detox she was 
tough. The doctor was tough now. But she was good. 
She did stand by what she believed in, like.”
Clients’ experiences of working with the Novas 
CD were universally positive. By far, the most 
common responses from clients were that they 
had complete trust in the team, felt supported by 
the team, and could confide anything in the team. 
Clients described their sessions with keyworkers 
as “having a chat” with a person of equal status and 
value. This experience was reported by every client 
contacted for this evaluation, and it attests to the 
success of the team’s concerted efforts to honour the 
dignity and worth of their clients. One keyworker 
described her approach this way: “I suppose, [] 
how you interact with them, you know, that you be 
open with them, that you give them your undivided 
attention, that you give them that space, that time, 
that you don’t question them too much. All done 
through a nice gentle approach, conversation, you’re 
not bombarding them with questions, you’re not cross 
examining, you don’t use any sort of authority, we’re 
both on the same page.” See the section below, Team’s 
Techniques for Working with Clients, for more 
information on this theme. 
JOBS, EDUCATION, AND ACTIVITIES OF DAILY 
LIVING
Interviews with clients demonstrated that 
the team actively works to encourage clients to 
identify activities in the community in which to 
engage, such as paid employment and education. 
One client who had completed both detox and 
aftercare described her initial resistance to her 
keyworker’s encouragement to get out of her house 
and do something - initially, her response was 
“nope, I can’t”, but then she “applied for a part time 
job, it’s a cleaning job in Tesco’s but I got it and three 
years later I’m still there.” Another client who was 
in the aftercare phase at the time of the interview 
described how she had recently gone from part-
time to full-time work, and that her keyworker was 
helping her deal with the challenges and stresses 
of going from working four hours a day to working 
eight and a half hours per day. Other clients 
described a range of activities offered by Novas and 
other community resources like the local university. 
Opportunities for yoga and meditation were 
frequently cited by clients as valued resources.
EMOTIONAL AND PSYCHOLOGICAL SUPPORT 
All clients described feeling that they could 
count on, and call on, keyworkers at any time, day 
or night. “Even when I was in the last week of my 
medication, I went [on holiday] and Julie rang me 
and just cause I had a major panic attack over there 
my heart  [pounding] in my chest and I didn’t take my 
meds right, and she’s been great like. Oh god yeah 
because it’s a friendly environment as well like they’ll 
ring you Sunday to Sunday like Julie if I needed to talk 
to her she’s there for me like”. 
Importantly, the team succeeds in 
communicating to clients a genuine concern for 
their well-being and an authentic interest in their 
lives. For example, one client said: “she just she cared 
like, do you know? It wasn’t just, I don’t think it was 
just her job, she actually cared what was going on like. 
Even after I had him [her baby] now, we stopped the 
programme, she still called out to see me after I had the 
baby like... she still took the time to ring and to call out 
and see the baby after I had him.”
Many clients do not have any other sources of 
positive social support, and so for them, the team 
may be their only authentic sense of connection to 
others, of a sense that someone believes in them, 
cares about them, and can be relied upon and 
trusted. A common refrain was that clients found 
it easier to speak to and seek social support from 
outside than from within their families. Further, 
clients described the ways that key workers worked 
with them to develop insight into their own roles in 
conflict with their family members: “Like any time 
I had a problem with anyone, she was only a phone 
call away, do you know? That’s and it was grand, 
because she was a complete stranger, but I felt like she 
cared more than my own family did, do you know? 
‘cause I don’t- don’t get on with everyone. I was always 
fighting. I know that I was a major factor in that. I can 
see that now.”
FAMILY SUPPORT
Clients described the varied ways in which 
the team involves family members and works 
to re-establish positive relationships, to develop 
new communication skills, repair damage done 
through drugs misuse, and develop family members’ 
understanding of what the client is going through. 
One client described how her keyworker got to 
know her family members and listen to their sides 
of the stories, then helped the client develop more 
effective ways of communicating with her family 
this way: “Even with my family, like, she’s been great 
to help them understanding [me]; [my family have] 
never understood me before. She’s [Novas CD key 
worker] heard my mother’s side of the story, she’s 
heard my nana’s side of the story, and she’s heard my 
side of the story, but when she talks [to us,] she doesn’t 
allow that she’s on our side, or their side, [] and it just 
calms me down then and makes me think: instead 
of [] [my] mother, like ...at least now, [] if [my family 
member is] not listening, I’ll write … down [what I 
want them to hear and] give it to them on paper, and 
then they understand it, like.” 
Clients’ Experiences of Novas CD
Key Informants from other drugs services in the 
region highlighted the important role the Novas 
CD plays in decreasing the risks associated with 
community detox. As mentioned earlier, one Key 
Informant used the metaphor of a “safety valve” for 
GPs. As described above in the GPs experiences of 
working with Novas CD, this Key Informant from 
another drugs service believes that “the CD workers 
act as a safety valve for GPs, who are reassured in 
providing a high risk service, when they know there 
is someone in the community checking in with the 
patient and looking after them.” This Key Informant 
went on to say that his impression is that some GPs 
don’t have a very good understanding of detox, 
that they want to do it too fast, and that speed can 
cause more harm than good. His impression is that, 
by following the protocols, the Novas CD worker 
can slow down the process for both GPs and for 
Other Services’ Experience of the Novas Community Detox
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clients, who can be eager to complete the detox. 
This is the importance of the preparation meetings 
and diary work as laid out in the protocols. This 
Key Informant has worked with some of the clients 
who have gone through the Novas CD, and it is 
his experience that clients think the programme 
is difficult, but that the keyworker is a “huge 
bonus of support and encouragement.” This Key 
Informant also said that clients who go through the 
community detox process and then return to him 
for rehab are “far better placed and prepared for it 
because [inpatient rehab] is abstinence based, and 
so people who have come completely off the benzos 
can manage it better. It really- really- really works 
well, and is the perfect lead-in to rehab....It’s a really 
good, neat service and it’s too bad it isn’t available 
nationwide.” He also said he would like to refer 
clients from other locations, for example, in Galway, 
but unfortunately the Novas programme doesn’t 
cover Galway and there isn’t a community detox in 
that region. 
Interviews with team members revealed the 
amount of time and effort they put into building 
relationships and trust with clients, as well 
as the tools and skills they put to use to build 
these trusting relationships. These efforts begin 
immediately, in the engagement and preparation 
phases of the programme. The drug diaries are 
an important tool in relationship and confidence 
building during the preparations stage and are used 
to assess a person’s readiness for change: “I feel the 
client will verbalize where are there at when they meet 
with ourselves will be very quick to give you the diary 
and goes, that’s how I was and then verbalize what 
went on during the week but in the preparation stage. 
It very much varies from person to person, and we 
have to have a certain amount of weeks of diaries and 
engagement, I suppose to separate the wood from the 
trees, to see who is genuinely interested, and to see, 
you know what I mean, who’s willing to give it a good 
go or not...I think that we recognize that this as well 
that the preparation stage has to be as it is, because 
you know, you have to get to know someone, you 
have to build a rapport with them, you have to build a 
relationship with them, you have to see where they’re 
coming, from you have to see what their commitment 
level is, given the fact that you’re dealing with benzos.”
SENSITIVITY TO CLIENT’S PAST EXPERIENCES
The team is keenly aware that their client 
population has had negative experiences with 
authority figures - sometimes lifetimes of negative 
experiences - and work to relate to clients in ways 
that attenuate status differentials between client 
and keyworker in order to build clients’ trust. “A lot 
of the clients we would deal with...would have an issue 
with authority, and rightly so, because they’ve had 
terrible experiences, so you use a nice, steady, gentle 
approach. You use all the skills that you have: you’d be 
genuine, active listening, you’d be open, to be honest, 
mindful of your body language, and that is that. The 
client [will] talk to you bit by bit and you take it at 
their pace. You don’t expect them to go at your pace. 
It’s their programme and you’re always mindful that 
they are your employer because if they weren’t there, 
we wouldn’t have a programme and you wouldn’t be 
employed, so you go at their level and their pace and 
if they’re willing to open up to you, [] you don’t you 
know push them too fast, too hard. That’s how the 
trust is built up and then they kind of think, “well, 
Julie’s alright or Maurice is alright.”
WHEEL APPROACH TO SUPPORTS AND 
RELAPSE PREVENTION
The team has taken a ‘wheel approach’ to 
interagency and community support building 
with clients. Their aim is to slowly but effectively 
replace the client’s primary relationship with 
benzodiazepines with other, more adaptive 
relationships, beginning with the team and 
expanding outward to family, community, and 
other client-chosen personal and social resources 
and capacities. As described by one key worker, 
“The primary relationship is the client and the 
benzodiazepine, and that is a central relationship 
when they come to us. Then you have the client the 
benzodiazepines and community detox, so we’re after 
being introduced. And here along comes the GP, so 
this is the ideal, as we envisaged it, that as the client 
continues with community detox, support structures 
and enhancements to their life become apparent...
and we try and help people to work towards so when 
it’s gone we aren’t back at stage one...So [for example] 
that’s what the meditation is: an attempt at giving 
them...a different experience of the world so that when 
the substance is gone it’s [their world] not empty.”
A WARM, INVITING ENVIRONMENT
Several clients commented on the warm, inviting, 
“cosy” atmosphere of the community detox meeting 
room. The keyworkers remarked on the efforts they 
have put into creating a warm space, in contrast to 
the cold and spare spaces that are often encountered 
in social services. They also commented on how 
the clients use objects in the space to facilitate 
conversation and connection with keyworkers. 
Interestingly, one object in particular, a statue of 
the Buddha, has emerged as a valuable resource for 
connecting to and developing intimacy with clients. 
For example, one keyworker said, “I had, there was a 
woman here the other day. She had a rough week, she 
had very little to say, but she honed in on the statue 
there of your man [referring to the Buddha statue there 
in the window] and sure, she was asking me, do you 
believe in God do you believe in heaven, do you believe 
in hell, do you believe in this, do you believe in that, and 
we had a fine chat around our spirituality and this and 
that and the other, what might happen when you leave 
this plane, and where you go. And I’d say about after 
about 40 minutes of that kind of chat we got around to 
how your week was.”  
LINK CLIENTS TO OTHER SERVICES
The team members work diligently to link clients 
to other community resources. Sometimes clients 
do not qualify for other services because of their 
drug misuse, and the team will work with them 
until they do qualify. One team member described 
the breadth of their efforts in this area like this: 
“you know like you would you would sometimes 
come up, come across people in the community with 
housing issues, so you would then come in with your 
appropriate housing body; with family support issues 
you know, young kids who might need a little a little 
extra help and a little dig out from, and you would 
link them in with Family Support Service, you would, 
when it’s female, when it’s health you know, you 
know, some of our females would have street worked 
and things like that in the past, so you would link them 
in with women’s health, you would link them in with 
the Regional [hospital], and support them throughout 
all of that.” 
TEAM WORKS WITH CLIENTS WHO LEAVE AND 
COME BACK
Analysis of referral logs and case files 
demonstrated that the team will repeatedly engage 
with an individual who leaves the programme 
and wants to return. They believe that prior 
engagement is an important foundation for future 
success. One key worker described the process 
this way: “This one girl I’m working with now, that 
I would have originally assessed in maybe July 2012, 
she was nowhere near in a shape for detox, and you 
know she fell out of the programme, but has come 
back around again this year, and she appreciates and 
understands the benefits of the diary, the benefits of 
the programme, of the preparation process.” 
 
TEAM MEMBERS’ EXPERIENCES OF THE TEAM
 Interviews with team members indicate that 
the team is a highly cohesive and effective team 
Team’s Approach to Working with Clients
Xerspedit, ut fugiasi tiumet, 
sandam landit acernam, 
ut volupta est officid 
endaecte arum, con nonse 
sitincipitam nos solupta 
velia et lab incia dolupidebis 
aligent omnis dolorum quo 
inctur? Quid ut il et qui 
dolupta tquae. 
“
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Key informants included doctors, clients, and key 
stakeholders with a range of different relationships 
to and experiences with the Novas CD programme. 
Across these different key informants, a great deal 
of confidence in and enthusiasm for this team 
was expressed. In fact, it was usually very difficult 
for Key Informants to name a weakness, gap, or 
dissatisfaction with the service. Only one doctor 
expressed some dissatisfaction with her experience 
of the programme, and this was described above in 
an earlier section. Thus, other than a single doctor 
who experienced problems with one client, Key 
Informants were hard-pressed to name a single 
weakness, and the evaluator did press each of 
them, sometimes quite firmly, to try to get a sense 
of areas in which the programme could improve. 
In the rare instance when a weakness or gap was 
finally named, it was either presented as a past 
problem that the team has already solved, or as a 
larger problem that is not actually within the team’s 
control. The two issues that were raised had to do 
with regularity of steering group meetings and 
feedback from the team to other drugs services:    
“…and one area that probably needed to be, um, 
looked at again was the steering group, and to be fair 
to Dan, we had that meeting. There was only a couple 
of us there a few people weren’t able to make it, but 
I think the steering group is important... so you have 
relevant players referral bodies et cetera, coming, 
meeting, feeding into how the project is actually 
working and anything we can do to provide support 
for Novas…So if I were going to say something about 
the evaluation, that’s definitely something that needs 
to be maintained ‘cause [steering groups] work well. …
To be fair, I was just flagging that they hadn’t met in 
a while, and we met five six weeks back and there’s a 
meeting due actually, shortly, so it’s back on track.” 
Another Key Informant said that at first, there 
may have been a bit of staff turnover that made it 
difficult to get a hold of someone in the Novas CD 
office, and that it still might be two or three days 
before he gets a call back, but that is a drawback of 
team members only working part time for the CD. 
Also, when he refers clients to Novas CD, they don’t 
always come back to him, and he wonders where 
they go. He would like for a team member to get in 
touch with him and let him know what happened 
to the client. 
Weaknesses or Gaps in the Programme
All Key Informants were asked if they had any 
recommendations for the programme or any ideas 
for the direction they would like the programme 
to take in the future. In this section, I summarize 
these recommendations and connect them to the 
programme’s current practices and development 
plan (Chapter 7). 
FEEDBACK TO REFERRAL SOURCES
As described above, one of the few gaps 
identified by Key Informants is information sharing. 
The team could review their policy and procedures 
for feeding information back to referral sources 
about client outcomes. 
BROADER COMMUNITY FOCUS
Some Key Informants stated that they like the 
broader community focus that the team has taken, 
which goes beyond their initial proposal for the 
service. Initially, the Novas CD was proposed to fill a 
gap in drugs services for a group of homeless adults 
who did not qualify for any of the available drugs 
services in the region. Some Key Informants felt 
that the original target population was too narrow, 
that they were heartened to see the programme 
take a broader community focus, and that they 
hope that the programme can grow this focus 
through additional funding, such as from the HSE, 
philanthropic funding, or private funding. 
STEERING GROUP
One Key Informant emphasized the importance 
of regular (quarterly) steering group meetings to the 
effective functioning and participation of a drugs 
programme within the larger network of drugs 
services providers in the region. It is important 
that the steering group consist of Novas staff, 
representatives from referral bodies like the HSE. 
The steering group is seen as an important resource 
for information sharing about trends in drug use, 
but also about particular service users and rehab 
planning: care planning, care referral pathways, 
case management, and intimidation concerns. Key 
informants suggested that the Novas CD should be 
encouraged to maintain a regular schedule of three 
to four annual steering group meetings. 
EXPANSION OF SUITE OF SUPPORT SERVICES
Key informants spoke about their ambitions to 
see the programme grow and become embedded 
within a larger array of services, within the 
larger Novas Initiatives host organization, and 
become, as one informant put it, “a little kind of 
continuum of care within an organization”. Key 
informants observed that the Novas CD team is ripe 
for developing such a diversified service: “Yeah, 
they’re good at it, they can manage it, it’s bloody 
challenging work, but they can do it.”
EXPANSION OF DRUG SERVICES TO ALCOHOL, 
OTHER DRUGS, TREATMENT OF INDIVIDUALS 
WITH DUAL DIAGNOSIS AND DUAL 
ADDICTIONS
Key Informants raised the seemingly intractable 
challenges of treating dual diagnosis and dual 
addictions, and voiced aspirations for this team to 
be on the vanguard of regional solutions to this 
problem. One Key Informant said he would like to 
see the detox expanded if possible. He would like to 
see the Novas CD work with clients on heroin and 
methadone detox, because there really is nowhere 
for them to go. It is unclear, however, that there 
is a great demand in the region for methadone 
detox. There is a protocol for methadone detox, but 
interviews with the CD Coordinator indicated that 
the demand for methadone detox is lower than the 
demand for benzo detox. Further complicating the 
matter is a high rate of dual benzo and methadone 
addictions in the region, and it is the understanding 
of this evaluator that the preferred order of detox is 
benzos first, then methadone. This issue is taken up 
again in Chapter 7.
Key Informants talked about the Novas CD team 
as having both the ethos and the competencies that 
are necessary to take the lead in treating poly-drug 
misuse. One Key Informant raised the issue of 
alcohol dependence and the need to address dual 
benzo-alcohol dependence in community detox 
and relapse prevention, and said that he would like 
to see the team obtain the funding and supports 
who are passionate about their work and enjoy 
working with one another. They have developed 
methods and strategies to deliver community detox 
that maximize efficiency and effectiveness. One 
team member put it this way: “I suppose we are small 
team, and I have no qualms in saying we are very good 
team, you know what I mean, and we really are well 
connected together, and well bonded. We work so well 
together that we don’t even have to give each other a 
nod and a wink. I think some of the things we do just 
happen to have just developed, and they’ve proven 
to work. I would never have sat down and have this 
magic, and had this writing it down, and this is what’s 
going to happen after so many weeks or whatever.” 
However, if the team has developed procedures 
and strategies to deliver the community detox 
that they believe are proven to work, it would be 
useful for them, for future team members, and for 
other community detox teams, if they were able to 
document these strategies and develop an evidence 
base for what works and why it works. 
Recommendations
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necessary to upskill in this area. However, he also 
said, “That’s bigger picture stuff, that’s national 
strategy stuff: are they are going to include alcohol in 
the strategy or are they going to have alcohol here and 
drugs here? And they’ve had that separation for quite 
some time now they have it for some reasons. From a 
law perspective it’s one that can be a little complicated 
(minimum pricing and all this kind of stuff - that’s 
another area of work) but for me, alcohol should be 
included ‘cause poly-drug use is a massive, massive 
factor… they [Novas CD] are, they’re ideally placed 
and, and, there are, there are, believe it or not, enough 
examples of alcohol only users as well, for example an 
issue we have is that the HSE drug and alcohol service 
don’t provide services to individuals over the age of 25 
who don’t have an alcohol only dependency because 
they used to fall under the MH services.”
Accessing services for clients with dual diagnosis 
is a big challenge for this team. As one keyworker 
stated, “I suppose the big barrier within the Limerick 
area is mental health, you know, and it’s something 
that we are experiencing for as long as I’m in this line 
of work, as you know, pushing the book from one 
to the other: is it mental health or is it addiction? You 
know we are quite willing to recognize dual diagnosis 
from our end of the scale, but then mental health won’t 
recognize it and they’re telling you to deal with their 
addiction and they have to be drug free, they can’t be 
using you know before will see them period so that’s 
the big thing.”  
The team is involved in a pilot effort at Dromin 
House North Tipperary Mental Health Service 
in Nenagh to treat dual diagnosis. The team’s 
successes in this area could go some way to reducing 
barriers to mental health services that Novas CD 
clients encounter. As one keyworker described 
her experience working with Dromin House in 
North Tipperary: “and it is proven to work very well, 
it is proven to work particularly in North Tipperary 
where another agency would be making the referral 
it would be drug and health...the addiction counsellor 
there ...would be making the referral [to us] and for the 
first initial stage of the preparation, of me doing the 
assessment, and I suppose doing a bit of preparation 
work, getting the diaries up and going, he would work 
with me and even you know following along from that 
he would dip in and out all the time and that works 
really really well....I suppose it’s kind of showing the 
way it is a big step forward and how we can work 
with dual diagnosis and it’s nearly been an example 
for how we could work with the day hospitals here in 
Limerick, you know. It’s something that we can build 
and work on with other agencies, you know, making 
referrals we’ve had referrals from CSMT some of the 
lads down there, and they are fantastic you know. 
A NEED FOR WOMEN-SPECIFIC SERVICES
Some Key Informants raised concerns about the 
gendered aspects of drugs misuse, with a focus on 
both the high rate of misuse amongst women in the 
Midwest Region and on women’s particular needs 
and problems that arise from substance misuse. One 
Key Informant said: “We have very high numbers of 
young women between late teens to early mid-thirties 
that are using. And all the issues that come with using. 
So, uh pregnancy, street working, domestic violence, 
etc., early school leaving…Our numbers are way 
higher than the national average. Way higher… bar 
Dublin…it’s way above the national average. You’re 
talking 20-odd percent.” Incorporation of women-
specific services is on one Key Informant’s agenda 
for drugs services projects within the region, and he 
would like to see the Novas CD add women-specific 
services to their programme. 
SUSTAINABILITY
One issue that Key Informants raised is 
sustainability. At the moment, Community Detox 
fits under the MWDAF treatment and rehabilitation 
pool, so it draws from a pool of money along with 
other projects in the region. Because the programme 
has demonstrated itself to be a vital component of 
the continuum of care in the Midwest Region, it is 
important that it secure dependable funding for the 
long-term. One Key Informant said, “it’s a project 
that needs to stay given the nature of what it does.”
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KEY FINDING 1 – FIDELITY
The Novas Community Detox team provides 
community-based supports to clients and general 
practitioners with a high degree of fidelity to 
the Progression Routes Protocols. There are two 
important corollaries of this finding: 1) the team 
provides a highly effective and important service to 
the Midwest Region; and 2) the Progression Routes 
Protocols are a safe, effective, and cost-efficient 
means to deliver a community-based detoxification 
service.  
KEY FINDING 2 – INNOVATION
The Novas Community Detox programme goes 
beyond the original Progression Routes protocols 
in ways that add value and increase effectiveness. 
The two most important adjuvant components are 
the expanded Broker-CD Coordinator Role and the 
dedicated key worker team members. Evidence 
from this evaluation suggests that outcomes for 
clients and general practitioners are enhanced 
when a team of trained drugs specialists deliver the 
protocols. 
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Key Findings, Sustainment and 
Development Recommendations
06
The first section of this chapter 
summarizes the key evaluation 
findings. The second section presents 
a set of key recommendations for 
sustainment and development that 
result from these key findings. These 
recommendations were generated 
in consultation with the CD 
Coordinator and Team Members and 
are intended to sustain and grow this 
this important community resource 
so that it may achieve its aim to 
satisfy Key Stakeholder interests 
and priorities and continue to safely 
and effectively deliver its service to 
residents of the Midwest Region. 
Key Findings
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KEY FINDING 3 – IMPORTANCE
The Novas Community Detox Team provides 
a service that fills a gap in the Continuum of 
Care, such that clients are served who would not 
otherwise be able to access detoxification because 
they would not qualify for residential services, 
because waiting lists are too long, and because their 
use is too high for general practitioners to agree to 
provide a detox without supports.  
KEY FINDING 4 – CLIENT SATISFACTION AND 
SUCCESS
Clients are highly satisfied with the services they 
receive from the Novas Community Detox team. 
The outcomes that have been obtained for clients, 
in terms of numbers of clients engaged, retained, 
returned, and completed, further support the 
conclusion that the team is providing a high-quality 
and much-needed service in the Midwest Region. 
KEY FINDING 5 – GENERAL PRACTITIONERS’ 
ENGAGEMENT
The Team provides valued supports to GPs who 
would otherwise not be comfortable delivering 
a community detox to individuals with such 
high rates of benzodiazepine use. Some GPs 
continue to have reservations about the potential 
for some individuals to successfully detox from 
benzodiazepines, but they often willing to take on 
the responsibility with the supports of the Novas 
CD Team. The GPs trust, respect, and rely upon the 
Novas CD Team to provide essential supports to 
reduce risk and support clients through detox. 
KEY FINDING 6 – VALUE TO KEY 
STAKEHOLDERS
Key Stakeholders have a positive evaluation of 
the Novas Community Detox Team. The team was 
referred to as the “gold standard” for delivering 
the Progression Routes Protocols. The service is 
universally seen as a cost-effective means for 
delivering a service and filling a gap within the 
drugs services continuum of care in the Midwest 
region. The team members are universally appraised 
to be highly competent, passionate, and skilled 
specialists.  Also universally, Key Stakeholders 
would like to see this team grow, both in size and 
type of services it offers to its clients. 
KEY FINDING 7 – TEAM EFFECTIVENESS
Team members are highly knowledgeable, 
experienced, passionate, and committed to their 
work. They deliver the protocols with both 
professionalism and compassion.  The team is 
highly cohesive, respect one another, and effective 
in their working relationships. The intangible but 
vitally important working relationships that have 
developed amongst the team members are one of 
the key ingredients that have contributed to their 
successes, which include widespread uptake of 
the service by general practitioners, respect and 
support of Key Stakeholders, and most importantly, 
their clients’ high degree of satisfaction with their 
experiences of the service. 
Recommendations
Given the success Novas Initiatives’ CD team 
has had with their approach to delivering the 
Progression Routes Protocols to individuals detoxing 
from benzodiazepines, several recommendations 
for programme development and expansion are 
warranted. These recommendations fall into four 
categories: 1) broaden the target population; 2) 
increase resources; 3) Enhance regional presence; 4) 
Enhance national presence. 
1. Broaden Target Population 
It is recommended that Novas Initiatives broaden 
their target population to include individuals 
whom they could support through detox from 
other substances. Given the current rates of 
alcohol and codeine misuse and dependence in the 
Midwest Region, it is recommended that the team 
collaborate with experts to develop adaptations 
of the Progression Routes Protocols for alcohol 
and codeine, pilot and evaluate the delivery and 
effectiveness of these new protocols. 
2. Increase Resources
Funding. In order to grow this important 
service, the team will require additional resources, 
especially funding. A dependable, ring-fenced 
funding stream is a necessary prerequisite to 
the team’s achievement of their long-range 
development goals. The team should also apply 
for funding from additional funding streams, for 
example, funding streams that are tied to particular 
specialisms or target groups.
Space: Right now the team is at capacity in the 
space that they have, and although they use the 
space in creative ways, they cannot expand until 
they have more space. As the CD Coordinator 
pointed out, because it is community detox, the 
team members should spend much of their time 
in the community. But they need desk space, they 
need meeting space, and, if they do increase the 
range of services offered to clients, then they need 
space in which to deliver these services. 
Staffing. In order to reach more clients with 
a greater diversity of support needs, an increase 
in staffing numbers is required. Currently, 
staff members are employed part-time on the 
Community Detox Programme. These staff 
members could easily fill 40 hours per week 
devoted solely to delivering community detox 
supports. It is recommended that staffing hours 
be increased commensurate with the level of 
development desired by Staff and Management. 
This could take the form of current staff moving 
from part-time to full-time, and/or the hiring of new 
team members. 
Skills. Two areas of staff upskilling are identified 
as important to maximizing the effective support 
of community detoxification. The first is Trauma 
Informed Care. Given the substantial percentage 
of Novas CD clients with histories of trauma, 
it is important that all staff are trained in the 
delivery of Trauma Informed Care via the model of 
Psychologically Informed Environments (PIE). The 
second is Cognitive Behavioural Therapy (CBT). CBT 
is an evidence-based practice with a large body of 
research demonstrating its effectiveness for anxiety 
management. Benzodiazepine misuse is strongly 
associated with anxiety symptoms, and because 
virtually every Novas CD client to-date reports 
problems with anxiety that interfere with their 
daily functioning, it is important that each team 
member be trained to deliver CBT. 
3. Enhance Regional Presence  
Other Agencies. To maximize their capacity to 
support their clients through detox, and to capitalize 
on resources already available in the Midwest 
region, the team should continue to strengthen 
their interagency work in the sector with services 
such as ALDP and CSMT. It was suggested by some 
Key Stakeholders that the Steering Committee is 
underutilized. It is recommended that the team 
think about the composition of their Steering 
Committee and the ways in which they use the 
Steering Committee to ensure effective delivery 
of services and strong interagency connections at 
local, regional, and national levels.
GPs. It is also recommended that the team 
continue GP trainings in order to increase their 
involvement with Novas, their comfort and 
confidence in delivering community detox, 
particularly in line with the recommended 
guidelines as explained in the Progression Routes 
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Protocols. This training should be expanded to 
include other agencies like probation and social 
work, in order to increase understanding of 
substance dependence, knowledge of best practices 
for community detox, and empathy for individuals 
facing the challenges of substance misuse and 
detoxification. 
Other institutions. It is also recommended to 
strengthen and enhance existing links between 
Novas and University of Limerick and Limerick 
Institute of Technology. The development of 
practitioner-researcher interconnections, perhaps 
through a series of annual seminars or meetings, 
in which information can be shared about theory 
and practice. These may be part of professional 
development, training, and outreach. Linking with 
UL and LIT in official capacities can increase the 
profile of all three institutions. 
Geographical Reach. It is recommended that 
staffing grow to allow for the development of a 
greater presence throughout the region, where 
coverage is necessarily thin because of the small, 
part-time staff. The presence of the team at Dromin 
Day Hospital in Nenagh is well-established, but 
opportunities to grow beyond the connection to 
Dromin should be explored. The geography, size 
of the region, and spread of the population into 
rural areas make it difficult to grow services in 
Clare, Limerick County, and North Tipperary. It is 
recommended that the team and its management 
explore opportunities to create satellites in sites such 
as West Limerick, Ennis, Thurles, and Newcastle 
West, which could be staffed with individuals who 
can network and build relationships with service 
providers and GPs
4. Enhance National Presence
At present, Novas statistics are not included 
in the Health Research Board or NDTRS reports 
because only inpatient statistics are included. This 
exclusion of outpatient and community-based 
services systematically underrepresents both 
the extent of need for services and the volume 
of services provided in response to this need, 
especially in the Midwest Region. Because the level 
of services provided by Novas CD in the Midwest 
Region is substantial, this means that rates of use 
and service provision documented in these reports 
underrepresent both the level of benzodiazepine 
use and the intensity of drugs services in this 
Region. Novas Community Detox statistics should 
be included in these national reports in order 
enhance their national visibility, but also to improve 
representation and accuracy of national estimates of 
benzodiazepine use. 
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APENDIX
INITIAL REFERRAL FORM
• Date of referral
• Age
• Sex
• Location
• Employment status
• Type of accommodation
• Number of dependents 
• Child care arrangements
• Legal status – citizen/immigrant
• Nationality
• Drug preference & current drug use
• Injection history
• Age of first drug treatment
• Previous types of drug treatments (“drug 
contacts”)
• Methadone – current, amount, duration
• Prescribing doctor
• Other medications
• Medical card
• Legal situation – Legal issues
• Referral source
• Other support services
TREATMENT OUTCOMES PROFILE (TOP)
• Substance Use: Measure, average daily, weeks 1 to 
4; I need this measure explained to me
• Alcohol
• Heroin
• Methadone
• Crack/cocaine
• Amphetamines
• Cannabis
• Ecstasy
• Benzos prescribed and unprescribed
• Other sedatives
• LSD
• Other
INJECTING RISK BEHAVIOUR
• Number of days injected
• Times injected per day
• Used by someone else
• Spoon water filter used by someone else
Health and Social Functioning
• Psychological health
• Physical health
• Housing problem, risk of eviction
• Quality of life
Record of Disengagement
• Date of disengagement
• Stage at which disengaged
• Y/No continued contact
• Reason for not beginning detox (as appropriate) 
OR how disengaged during detox
Quantitative Data
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Qualitative Data
CLIENT INTERVIEW GUIDE
1. Tell me a little bit about yourself.
2. Describe the admissions process – referral, 
assessment, meeting with the coordinator, 
meeting with the MD, meeting with the key 
worker. 
3. Describe the detox process and any particular 
aspects of it that you think are important.
4. Strengths and weaknesses of the programme for 
you. 
5. Did you complete the programme? At what 
point did you discontinue?
6. Describe experiences of the preparation period. 
7. Describe experiences of the detox period. 
8. Describe experiences of after care. 
9. Describe experiences of leaving/finishing/
disengaging from the programme. 
* Prompts for the above: How did you experience 
the pace of the programme – the preparation period, 
the prescribing period, and any other part of the 
programme?
10.  Describe any experiences of relapse. 
11. What kinds of services are there for you now? 
What do you think you need?
12. Would you reengage with the programme?
13. How satisfied are you with your experience of 
the programme?
14. Would you recommend it for other people?
GP INTERVIEW GUIDE
1. Describe your experiences of and general 
appraisal of the community detox programme. 
2. How many clients have been referred to you, 
how many have you accepted?
3. What were your experiences of working with 
the coordinator/broker and the key workers?
4. How familiar are you with the community detox 
protocol, what are your thoughts about it? 
5. What do you think works, doesn’t work, could 
be improved about the community detox 
programme and protocol?
6. What are your thoughts on clinical governance?
7. Thoughts on dual addictions and dual diagnosis
8. Treatment concerns – reservations about 
participating
9. If you haven’t accepted any patients, why? If 
you’ve declined to take on some referrals, why? 
What were your concerns?
10. What are your thoughts on clinical governance?
KEY STAKEHOLDER INTERVIEW GUIDE
1. Is the programme providing treatment options 
that weren’t there before? 
2. Do individuals who need it avail of it?
3. Do the doctors benefit from the supports 
provided by the key workers?
4. Does it help them deliver this high risk medical 
service?
5. What is the value of programme? 
6. What are its strengths and weaknesses? 
7. What is its relevance to or role in providing 
drugs services in the Limerick context?
8. How does it function, in terms of governance 
and oversight? In terms of operations and 
management? 
9. What are your expectations for the programme 
moving forward?

